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Supplementary Materials and Methods 
Mouse male and female GBM cells.  
Male and female astrocytes were isolated from the neocortices of postnatal day 1 Nf1fl/fl GFAP Cre mice and genotyped 
for sex using Jarid1c and Jarid1d PCR. Male and female Nf1−/− astrocytes were then infected with retrovirus encoding a 
flag-tagged dominant-negative form of p53 (DNp53) and EGFP resulting in male and female astrocytes null for Nf1 and p53 
function. The DNp53 plasmid consists of amino acids 1–14 of the transactivation domain followed by amino acids 303–393, 
thus lacking the DNA binding domain. Cells were grown in DMEM/F12 media supplemented with 10% FBS and 1% penicillin-
streptomycin. These astrocytes serve as a model of GBM and are referred to throughout the text as male and female GBM 
astrocytes. Cell cycle analysis and metaphase spreads of male and female GBM astrocytes reveal similar aneuploidy with 
2N and 4N subpopulations with varying and overlapping chromosome numbers that ranged between 50 and 120, and 41 
and 111 respectively (1).  
 
Chromatin immunoprecipitation sequencing (ChIP-seq) for H3K27ac.  
10 million male and female GBM cells were treated with 0.05% DMSO or 500 nM JQ1 for 24 hours. Following treatment, 
cells were then prepared for various downstream analyses including ChIP-seq for H3K27ac. Briefly, cells were fixed in 1% 
formaldehyde prepared in DMEM/F12 and incubated for 10 minutes at room temperature with gentle rocking.  Fixation was 
quenched by the addition of glycine to a final concentration of 125 mM and incubation for 10 minutes at room temperature 
with gentle rocking. Cells were then washed with cold PBS and harvested by scraping in 5 ml of cold PBS.  Cells were 
transferred to 15 mL conical tubes and pelleted with a 5-minute spin (1,000g) at 4ºC. Sonication was performed on an 
Epishear probe-in sonicator (Active Motif) at 40% amplitude for 8 cycles of 30 seconds, with 30 seconds of rest between 
each cycle.  ChIP-seq libraries were constructed as previously described (2), with an antibody that recognizes H3K27Ac 
(Active Motif, 39133, rabbit polyclonal). ChIP-seq libraries were constructed with sample-specific barcodes, and pooled 
before sequencing on a HiSeq 2500 (Illumina). 
 
RNA-sequencing.  
Male and female GBM cells (Nf1-/-;DNp53 astrocytes) were generated as previously reported (Sun et al., 2015) and grown 
in DMEM/F12 media supplemented with 10% FBS and 1% penicillin-streptomycin. Total RNA was isolated from male and 
female GBM cells that were treated with DMSO (0.05%) or JQ1 (500 nM for 24 hours) using the RNeasy Mini Kit from 
QIAGEN (Hilden, Germany), following the kit protocol. PolyA Selection was performed to create RNA Seq libraries. Cell 
mRNA was extracted from total RNA using a Dynal mRNA Direct kit. The quantity of RNA was measured using a 
spectrophotometer (NanoDrop 2000c; Thermo Scientific). Samples with an RNA concentration A260/A280 ≥1.8 ng/μl, and 
purity A230/A260 ≥ 2.0 ng/μl were selected. The Agilent 2100 Bioanalyzer was used to determine the RNA integrity number. 
The degradation level was identified using the RNA 6000 Nano LabChip kit (Agilent). Samples with RNA integrity number 
> 9.8 were further processed using TruSeq mRNA Library Preparation Kit (Illumina) and then sequenced on a HiSeq 25000 
(Illumina).   
 
Pathway analysis.  
Pathway enrichment analysis for differentially regulated genes was performed using a combination of KEGG pathway and 
Genomatix Pathway System (GePS). GePS uses information extracted from public and proprietary databases to display 
canonical pathways and or to create and extend networks based on literature data.  These sources include NCI-Nature 
Pathway Interaction Database, Biocarta, Reactome, Cancer Cell Map, and the ENCODE Transcription Factor project data. 
All data for pathway analyses are presented with adjusted corrected p-values. 
 
Human glioblastoma stem cells (GSCs) gene expression data analysis. 
 RNA-sequencing data were derived from GSCs published in Mack et al., 2019 (3). Data from FASTQ files were trimmed 
with TrimGalore, which implements Cutadapt (4) and FastQC (5), to remove low quality reads and trim adapaters. Reads 
were aligned to Gencode v29 using Salmon (6) with correction for GC bias, positional bias and sequence-specific bias. The 
R/Bioconductor (7) package tximport (8) was used to generate TPM values. Low expressed genes without at least 1 count 
in 4 samples were excluded from analysis. Comparisons were performed using DESeq2 (9) on raw counts. 
 
Quantitative Real-Time PCR.  
Total RNA was isolated using QIAGEN RNeasy Mini Kit from male and female GBM cells (Nf1-/-;DNp53 astrocytes) infected 
with shRNA lentivirus against Brd2, Brd3 or Brd4. cDNA was generated using the QuantiTect Reverse Transcription Kit 
(Qiagen). Quantitative RT-PCR was performed using gene-specific primers and iTaq SYBR Green PCR master mix (Biorad, 
CA). Data was analyzed by standard ΔCq method (2-ΔΔCq) where ΔCq is the difference between the gene of interest and 
GAPDH control Cq value. Sequences for primers specific for each Brd family member are provided in SI Appendix, Table 
S5. 
 
shRNA lentiviral infection and knockdown of Brd2, Brd3 and Brd4.  
Brd2, Brd3 and Brd4 knockdown lines were generated by infecting male and female GBM cells (Nf1-/-;DNp53 astrocytes) 
with lentiviral shRNAs against Brd2, Brd3 or Brd4.  All Knockdown lines were selected with puromycin (2.5 µg/ml) in media 
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for 1-2 weeks and the survivors were expanded for downstream target knockout analysis. Five different shRNAs specific to 
each of the Brd family members were evaluated and the shRNA with the most robust knockdown was used for the 
downstream functional experiments. Sequences for shRNAs are provided in SI Appendix, Table S5. 
 
Clonogenic cell frequency assay: Extreme Limiting Dilution Assays (ELDA analysis).   
Male and female mouse GBM cells (Nf1-/-;DNp53 astrocytes, 2 lots of male and female cells) or human male and female 
primary GBM cell lines (3 male and 3 female human primary GBM cell lines were kindly provided to us by Dr. Albert Kim) 
were treated with DMSO (0.05%), iBET762 (4 µM), CPI203 (0.5 µM), CPI0610 (1 µM), JQ1 (500 nM), OTX015 (2.5 µM), 
PFI1 (5 µM) or RVX-208 (5 µM) for 24 hours or with shRNAs against Brd2, Brd3, or Brd4. The timing and dosing of each 
drug was based on previously published data (10-14). Clonogenic capacity was then assessed by the Extreme Limiting 
Dilution Assay (ELDA). The frequency of clonogenic stem cells was evaluated by the cells’ ability to form tumor-spheres in 
low-adherent conditions as previously reported (15). Briefly, cells were harvested into a single cell suspension and plated 
in neurosphere media containing EGF, FGF and mouse LIF on 96-well ultra-low attachment plates in a serial dilution ranging 
from 3000 cells/well to 1 cell/well (3000, 600, 120, 24, 5 and 1 cells; n=14-18 wells/cell density). Sphere formation was 
measured 7 days after plating. Clonogenic cell frequency was then analyzed using the Extreme Limiting Dilution Analysis 
software (16). 
 
Growth assays.  
Growth kinetics of male and female GBM cells (Nf-/-;DNp53 astrocytes) treated with DMSO (0.05%), JQ1 (500 nM), or RVX-
208 (5µM) for 24 hours were examined by counting live cell number using an automated T4 cell counter as previously 
described with minor modifications (15). Briefly, cells were harvested and plated in a 6-well plate at a density of 2 x 104 
cells/well (2 technical replicates per treatment/genotype/time point). 4 hours post plating, cells were harvested by 
trypsinization and counted in the presence of trypan blue. This time point was designated as the starting point (T0) of the 
time course. Cells were then harvested and counted every 24 hours for a total of 3 days (24, 48 and 72 hours). This 
experiment was repeated three times. 
 
Cancer Therapeutic Response Portal data analysis.   
Drug response data were derived from the Cancer Therapeutic Response Portal (CTRP). The outcome variable was area 
under the curve (AUC) for each cell line and drug treatment. Glioblastoma cell lines were segregated by male vs. female 
sex, and AUC for each drug was analyzed by sex using the R/Bioconductor package limma (17). 
 
In vivo tumorigenesis: flank implantation.    
Flank tumors were generated by implanting GBM astrocytes subcutaneously into left side flanks. These cells were treated 
with 0.05% DMSO, 500 nM JQ1 or 1  µM CPI0610 for 24 hours, followed by EGF treatment at 50ng/ml for one week. 1.5 
million female cells or 5000 male cells treated with DMSO, JQ1 or CPI0610 were then harvested and resuspended in 100 
µl of 1:1 media to matrigel (BD Biosciences) and injected into the flanks of mice. Mice were monitored weekly and tumor 
growth and formation were monitored blindly for 8-16 weeks with thrice weekly micrometer measurements in 3 dimensions. 
Animals were used in accordance with an animal studies protocol (no. 20180206) approved by the Animal Studies 
Committee of the Washington University School of Medicine per the recommendations of the Guide for the Care and Use 
of Laboratory Animals (NIH).  
 
Bioinformatic motif analysis.  
To identify DNA motifs that are associated with sex-biased Brd4 binding, we used the HOMER toolkit (v4.11) (18).  Briefly, 
to find motifs enriched under male-biased peaks, we used the sequences under male-biased Brd4 peaks as input to 
HOMER, and used sequences from female-biased peaks, or all Brd4 peaks, as background.  We used the following HOMER 
command: (findMotifsGenome.pl mm10 -nomotif -preparsedDir -bg).  We found motifs enriched under female-biased peaks 
in a similar fashion using the corresponding sequence files.   
 
Statistical analysis.  
All experiments in this study were carried out at least three times. ELDA experiments with JQ1 and CPI0610 treatment were 
performed three times (n=3) in two or three different mouse GBM lots of cells, as indicated for each experiment. ANOVA, 
two-tailed Student’s t-test and Fisher’s exact test were used to compare the differences in all functional measurements 
between BET inhibitors and control group (DMSO), and a p-value < 0.05 was considered statistically significant. 
To test if upregulated genes in male cells compared to female cells and vice versa are significantly enriched for 
H3K27ac binding, the normalized H3K27ac signal intensities (reads) from 1kb upstream of the gene start site to 1kb 
downstream of the end of the gene were used for the correlation analysis. A paired Mann-Whitney-Wilcoxon test was used 
to compare normalized H3K27ac signal intensities between male and female cells and a p-value less than 0.01 was 
considered statistically significant.  
To investigate if Brd4-proximal genes are significantly downregulated upon JQ1 treatment compared to Brd4-distal 
genes, we first defined Brd4 proximal genes as the closest genes to Brd4 binding sites and Brd4 distal genes as genes 
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located near sites that are not enriched for Brd4 binding sites. Brd4 proximal and distal genes (500 genes each) were 
randomly selected. A Mann-Whitney-Wilcoxon test was used to compare the expression profiles before and after JQ1 






















































Fig. S1. Quality assessment of transposon Calling Card, H3K27ac ChIP-seq and RNA-seq experiments. Correlation 
heatmaps for transposon Calling Card (A), H3K27ac ChIP-seq (B) and RNA-seq (C, D) were prepared using replicates of 
male and female GBM samples. Venn diagrams in (B) depict the shared H3K27ac-enriched peaks among replicates in male 

























Fig. S2. BET inhibitors have differing effects on clonogenic stem cell frequency in male and female GBM cells. Frequency 
of clonogenic stem-like cells as determined by ELDA assay in male and female GBM cells treated with DMSO or (A) 
iBET762, (B) CPI203 (C) CPI0610 (D) OTX015 (E) PFI1. Male cells exhibited greater clonogenic cell activity than female 
cells under control conditions. BET inhibition reduced clonogenic cell frequency in male cells, while female cells exhibited 
































Fig. S3. Sex-specific response to BET inhibitor treatment is evident in human primary GBM cells. Normalized clonogenic 
cell frequency as determined by ELDA assay in male (A) and female (B) human primary GBM cells treated with DMSO 
(control), JQ1, or CPI0610. JQ1 treatment significantly reduced clonogenic cell frequency in human primary GBM male 
cells, and significantly increased clonogenic cell frequency in 1 out of 3 human primary GBM female cells. CPI0610 
treatment had a similar response pattern as JQ1 in male and female human GBM primary cells. (*=p <0.05, **=p <0.01 as 


































Fig. S4. JQ1 effect on gene expression in male and female GBM cells. (A) Heat map of gene expression changes (log2; 
upregulated in red and downregulated in blue) upon JQ1 treatment in male and female GBM cells. (B) Boxplot of gene 
expression changes (log2) of Brd4 proximal and distal genes following JQ1 treatment of male (blue) and female (red) GBM 
cells. The gene expression profile of genes in close proximity to Brd4 binding sites is compared to distal genes by a Mann-
Whitney-Wilcoxon test. Brd4 proximal genes are significantly downregulated compared to Brd4 distal genes in both male 
























































Fig. S5. Stem cell pathways regulated by sex-biased Brd4-bound enhancers. (A) Pathway analysis of sex-biased Brd4-
bound enhancers in male and female GBM astrocytes revealed an enrichment of stem cell pathways. Male GBM cells were 
highly enriched for cancer, neoplastic and pluripotent stem cell pathways. while female GBM cells were mainly enriched for 
neural stem cell pathways. Representative examples of these enriched pathways in male (B) and female (C) GBM 
astrocytes. Male-biased genes in stem cell pathways included oncogenes such as Myc, Tet1 and Lif, while female-biased 
genes included tumor suppressors such as Six 2 and Six 3. (D) Pathway analysis on sex-biased Brd4 regulated genes 
revealed that the cancer stem cell pathway was significantly affected by JQ1 treatment. Male genes (blue) were 
downregulated by JQ1 while female genes (red) were upregulated by JQ1. Value above/below gene box indicates the ratio 























Fig. S6. Brd4 is the main Brd family member responsible for the sex-specific response to BETi treatment. Normalized 
clonogenic cell frequency as determined by ELDA assay in male and female GBM cells treated with DMSO or the indicated 
BET inhibitor, with or without Brd4 knockdown. No significant difference in the effect on clonogenic cell frequency is 
observed between control and Brd4 knockdown cells treated with BET inhibitors, indicating that Brd4 is the main Brd family 
member responsible for this sexually dimorphic response to BETi treatment in male and female cells.  (*=p <0.05, **=p 


























SI Appendix Table S1. Pathway enrichment analysis for sex-biased Brd4-
regulated genes in male and female GBM cells as identified by Brd4 calling 
cards and H3K27ac ChIP_seq*  
Pathway description Adjusted  p-value # of Genes 
Male GBM Cells: 1740 genes   
Glioblastoma < 0.0001 349 
Cell proliferation < 0.0001 224 
Cell cycle  < 0.0001 152 
Regulation of transcription < 0.0001 113 
Tumor angiogenesis 5.00E-03 70 
Cancer stem cells  < 0.0001 41 
Epidermal growth factor receptor signaling 2.00E-03 15 
Female GBM Cells: 1604 genes   
Cell differentiation < 0.0001 386 
Glioblastoma < 0.0001 320 
Regulation of transcription < 0.0001 181 
Cell migration < 0.0001 161 
Neural stem cells < 0.0001 72 
Negative regulation of angiogenesis 1.00E-03 13 
Kinase suppressor of Ras 1.00E-03 8 




      




RNA-seq log2 fold 
change (male vs. 
female)  





ratio (male vs. 
female) 
Adjusted              
p-value 
H3K27ac log2 fold 
change (male vs. 
female) 
Adjusted              
p-value 
 
Col25a1 4.64 6E-09 21.28 1E-18 4.47 6E-25  
Blnk 4.64 1E-19 5.64 4E-10 5.42 3E-17  
Gm11549 4.60 3E-23 29.69 4E-125 3.73 4E-37  
Rassf10 4.52 8E-13 2.44 4E-04 3.00 8E-18  
Mlc1 4.38 1E-22 4.99 2E-06 1.98 3E-07  
Klhl13 4.31 2E-20 35.28 2E-40 0.85 1E-02  
Gng2 4.29 1E-23 22.64 2E-85 6.63 4E-28  
Cntnap4 4.24 5E-10 9.40 3E-12 3.96 4E-05  
Endou 4.22 5E-08 3.88 4E-03 1.96 6E-24  
Adssl1 4.18 6E-29 4.99 2E-06 0.67 2E-03  
Matn2 4.14 9E-32 4.16 3E-14 2.93 3E-04  
Xdh 4.12 2E-08 3.18 1E-09 1.14 3E-03  
Aldh1a3 4.04 2E-23 3.21 7E-18 1.31 2E-04  
Grpr 4.03 8E-14 26.73 6E-27 3.52 2E-02  
Pyroxd2 4.02 3E-06 2.99 4E-02 2.07 4E-04  
Galnt15 4.01 4E-20 5.60 4E-13 2.44 3E-04  
Foxl1 4.00 1E-11 3.18 4E-03 2.66 3E-25  
Gria1 4.00 1E-16 5.95 3E-19 2.16 7E-20  
Pir 3.99 1E-22 6.18 4E-10 1.72 2E-13  
Scml4 3.95 6E-27 2.21 4E-16 3.96 1E-08  
Ndp 3.93 4E-07 4.53 2E-74 1.41 2E-03  
Ahr 3.85 1E-25 8.88 2E-48 3.07 1E-06  
Lpar1 3.84 2E-24 5.40 2E-27 2.87 8E-05  
Ces1f 3.83 6E-13 2.07 3E-02 2.29 2E-14  
Ndnf 3.82 2E-08 3.86 7E-05 2.60 2E-03  
Gm10421 3.81 7E-10 9.50 9E-34 4.11 3E-10  
Fam167a 3.81 3E-16 4.76 2E-06 1.93 2E-14  
Lgals3 3.80 5E-08 1.88 1E-12 1.27 8E-11  
Fam19a2 3.79 2E-11 2.81 6E-37 1.21 3E-02  
Car2 3.78 8E-08 3.65 3E-07 1.94 2E-03  
Gprc5c 3.77 2E-06 5.16 2E-06 1.75 6E-04  
Npepl1 3.72 6E-21 4.34 6E-25 0.52 4E-02  
Mt1 3.72 6E-09 2.40 2E-02 0.84 4E-03  
Peli2 3.69 4E-06 2.80 8E-04 0.79 2E-02  
Fam83b 3.62 2E-06 58.36 1E-21 2.61 1E-04  
Frmd5 3.55 2E-05 1.94 1E-04 0.78 2E-02  
Cda 3.55 4E-15 3.14 4E-05 1.60 2E-03  
Pou3f2 3.53 3E-06 1.41 2E-06 0.62 2E-03  
Nalcn 3.52 1E-05 2.65 5E-77 1.49 5E-04  
Shtn1 3.50 4E-28 30.62 7E-33 4.37 7E-08  
Kcnn3 3.49 5E-21 3.57 2E-09 1.28 8E-12  
Crabp1 3.48 9E-05 85.68 1E-36 5.83 2E-36  
Pdk4 3.48 6E-26 1.59 2E-02 0.79 1E-02  
Mt2 3.48 1E-08 2.40 2E-02 0.84 4E-03  
Npy4r 3.48 1E-05 7.51 9E-10 0.74 3E-02  
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Pi15 3.46 3E-05 6.06 2E-15 1.92 6E-03  
Cpa4 3.43 6E-10 4.61 9E-06 2.26 1E-13  
Kazald1 3.43 2E-18 2.83 4E-13 0.79 4E-03  
Alk 3.42 7E-10 8.94 2E-18 3.37 2E-15  
Itga11 3.40 4E-06 4.30 1E-02 4.59 2E-12  
Sucnr1 3.40 3E-26 1.43 4E-04 1.36 9E-06  
Aqp1 3.39 4E-06 23.62 3E-21 5.81 3E-13  
Dock8 3.38 4E-06 4.63 5E-93 4.13 5E-21  
Loxl4 3.36 5E-33 2.99 4E-02 2.07 4E-04  
Trpv4 3.33 5E-16 13.58 4E-53 2.66 8E-23  
Cyp1b1 3.30 1E-04 10.80 3E-203 4.94 8E-19  
Cxcl14 3.28 5E-08 6.02 1E-05 2.18 3E-18  
Tgfbi 3.27 3E-18 9.74 2E-21 1.78 1E-12  
Kcnk10 3.26 2E-19 18.17 1E-14 1.20 4E-05  
Igf2bp3 3.25 8E-16 3.78 8E-15 1.99 1E-12  
A830082K12Rik 3.24 2E-26 1.84 6E-11 0.76 1E-02  
Trhr 3.23 2E-07 14.19 6E-186 4.03 5E-03  
Aldh3a1 3.23 3E-13 7.84 3E-20 0.77 7E-03  
Epha3 3.23 6E-18 4.10 4E-02 1.83 4E-04  
Slc22a4 3.22 4E-05 3.65 3E-07 2.83 4E-09  
Cdk18 3.20 1E-18 4.44 2E-07 1.67 6E-15  
Ccdc122 3.18 1E-18 2.60 4E-23 1.82 5E-03  
Meis1 3.17 6E-23 2.43 5E-04 4.64 9E-07  
Slc5a7 3.16 1E-03 12.77 5E-62 1.98 2E-10  
Tgm2 3.15 5E-23 10.14 4E-09 1.81 3E-14  
Sorcs2 3.15 2E-33 11.32 2E-16 1.14 3E-04  
Cgref1 3.11 7E-05 3.10 2E-12 1.45 3E-05  
Gpr85 3.09 1E-16 17.72 3E-36 4.54 7E-17  
Nr2f1 3.08 6E-30 2.58 6E-20 1.25 7E-07  
C1qtnf1 3.08 3E-15 6.02 1E-05 1.03 3E-07  
Gmpr 3.07 5E-19 2.82 3E-06 4.38 7E-10  
Pdgfb 3.06 1E-25 3.93 3E-08 0.89 1E-04  
Myo1d 3.06 1E-25 12.13 4E-38 1.86 2E-23  
Fam110c 3.03 3E-10 7.14 9E-30 1.26 9E-06  
Cd28 3.03 1E-04 2.98 3E-05 2.32 9E-04  
Shh 3.02 2E-13 9.72 3E-12 3.38 5E-06  
A230065H16Rik 3.01 1E-04 7.12 3E-11 1.21 2E-08  
Psca 2.99 2E-13 2.37 4E-03 0.57 7E-03  
Gprin3 2.98 4E-14 1.63 7E-03 0.84 2E-02  
Lgals2 2.95 5E-24 2.09 1E-03 1.43 1E-13  
Chst3 2.95 4E-16 2.96 5E-15 1.23 5E-13  
Aspa 2.95 5E-18 2.40 3E-09 3.88 1E-03  
Mettl24 2.92 2E-03 6.68 1E-28 6.49 2E-17  
Snhg18 2.89 2E-18 2.73 1E-07 1.75 2E-05  
Shisa3 2.88 3E-03 6.85 2E-30 1.65 6E-09  
Rasgrf1 2.86 3E-03 7.09 1E-26 1.92 2E-03  
Gsdmd 2.86 3E-12 2.13 2E-02 0.54 1E-02  
Ccdc3 2.85 1E-04 4.82 1E-05 1.65 1E-02  
Vtcn1 2.85 2E-04 3.11 1E-03 1.17 4E-02  
Artn 2.84 3E-03 11.00 2E-16 4.29 2E-57  
Ret 2.84 1E-04 3.40 1E-07 1.64 3E-09  
Adh7 2.84 6E-31 2.99 1E-05 2.50 6E-05  
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Foxd1 2.83 5E-05 4.04 1E-33 0.99 3E-07  
Hapln1 2.83 2E-03 2.21 2E-05 1.09 8E-04  
Tet1 2.82 2E-25 2.77 2E-07 3.53 2E-10  
Aebp1 2.81 7E-30 3.01 6E-03 1.90 6E-06  
Cd109 2.80 3E-35 2.55 2E-15 1.00 2E-03  
Cd300lb 2.78 1E-09 2.48 5E-09 0.86 7E-05  
Tmem200c 2.78 5E-03 4.15 2E-13 2.70 1E-33  
Apbb1ip 2.76 3E-20 3.56 9E-05 0.90 5E-04  
Sybu 2.75 3E-07 4.17 2E-04 5.41 1E-09  
Lipg 2.74 2E-15 2.09 3E-02 1.89 3E-07  
Sh2d4a 2.74 2E-03 3.44 2E-44 1.91 6E-03  
Nrp2 2.74 6E-36 2.48 3E-06 1.32 8E-05  
Krt80 2.71 2E-03 58.36 1E-21 2.05 2E-14  
Ddx3y 2.67 7E-03 107.53 1E-50 6.62 4E-19  
Agap2 2.65 1E-06 3.49 8E-13 1.34 1E-03  
Ccbe1 2.64 3E-06 9.73 2E-17 4.59 3E-06  
Tenm4 2.64 1E-21 6.02 1E-05 4.82 3E-37  
Efemp1 2.63 2E-34 4.33 4E-09 1.29 5E-10  
Krt87 2.62 7E-03 9.24 4E-48 4.17 2E-67  
Atp8a1 2.61 1E-30 6.85 2E-30 1.65 6E-09  
Crygs 2.61 6E-07 2.34 4E-08 0.68 2E-03  
Slc6a15 2.60 9E-03 69.29 5E-27 3.16 1E-36  
Traf1 2.60 1E-04 3.53 7E-11 2.88 8E-07  
Chmp4c 2.59 4E-11 3.80 7E-13 1.47 4E-02  
Dlx6os1 2.58 1E-06 3.40 4E-03 2.19 1E-06  
Mlip 2.58 4E-04 2.50 4E-02 2.61 1E-04  
Igfbp3 2.57 1E-19 3.63 1E-05 2.05 7E-23  
Papln 2.56 4E-03 4.69 1E-15 1.60 3E-02  
Nfatc2 2.56 8E-07 4.06 1E-04 1.80 6E-03  
Syt8 2.55 2E-03 5.23 4E-10 1.49 5E-14  
Gm4262 2.54 6E-05 1.74 5E-05 1.10 3E-07  
Mn1 2.54 5E-15 12.65 3E-114 4.14 1E-05  
Asb4 2.54 2E-03 3.61 2E-10 0.79 1E-02  
Ano1 2.54 2E-20 5.93 3E-28 2.71 1E-15  
Fam135b 2.53 8E-04 2.80 1E-10 2.21 3E-02  
Arhgef19 2.53 3E-17 1.62 2E-02 0.44 2E-02  
Mfsd6 2.52 1E-27 2.23 8E-03 1.37 3E-07  
Oacyl 2.51 1E-02 4.46 4E-05 1.32 6E-03  
Npas3 2.51 3E-35 1.87 4E-06 1.25 9E-09  
Dlgap2 2.51 2E-03 2.79 3E-02 1.60 2E-05  
Cd38 2.50 2E-05 2.16 3E-03 1.23 1E-04  
A930001A20Rik 2.49 1E-02 4.82 1E-05 1.17 4E-02  
Itgb8 2.48 2E-23 1.82 3E-07 0.68 2E-02  
AA467197 2.48 1E-03 7.11 1E-16 2.08 1E-20  
Sash1 2.48 1E-14 4.28 2E-15 3.24 4E-04  
Col1a1 2.48 7E-27 1.81 4E-02 0.77 4E-05  
Ttyh1 2.48 2E-06 7.26 9E-10 2.62 3E-05  
Nebl 2.48 2E-30 2.96 1E-07 1.00 4E-05  
A330074K22Rik 2.46 4E-12 3.28 8E-03 0.54 3E-02  
Faim2 2.44 1E-04 4.32 4E-05 3.23 2E-44  
Edn2 2.43 2E-02 6.02 1E-05 6.00 7E-14  
Pantr1 2.41 4E-22 1.43 1E-15 0.76 5E-03  
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Fgfrl1 2.40 6E-22 4.51 2E-03 1.84 3E-03  
Txlnb 2.40 5E-12 3.37 1E-03 2.22 6E-03  
Scd1 2.39 7E-21 5.52 7E-26 0.82 4E-04  
C1ql3 2.38 2E-17 2.39 1E-35 2.39 2E-03  
Edil3 2.38 3E-11 2.21 2E-05 1.09 8E-04  
Adgrg6 2.38 2E-36 8.44 2E-09 1.56 2E-03  
Sele 2.37 2E-03 9.23 4E-07 2.56 4E-05  
Pde8a 2.36 1E-31 2.06 1E-03 1.16 2E-05  
Hspb7 2.36 3E-04 3.53 2E-16 1.19 2E-05  
Agmo 2.35 2E-02 72.02 7E-29 1.99 1E-02  
Col1a2 2.32 8E-27 3.75 1E-67 1.44 6E-09  
Kcnj16 2.31 2E-02 6.27 2E-06 1.20 5E-08  
Plb1 2.30 4E-12 1.72 2E-02 1.27 5E-12  
Fbn2 2.29 4E-17 18.17 1E-14 4.99 9E-15  
Rem2 2.29 3E-03 1.86 3E-02 0.62 3E-03  
Upp1 2.27 1E-09 3.35 1E-05 1.27 3E-03  
Arhgef3 2.27 2E-03 9.07 7E-35 1.34 2E-04  
Scube3 2.24 2E-14 80.21 1E-34 6.79 4E-29  
Zkscan2 2.24 5E-03 7.93 8E-37 5.58 1E-10  
Egr3 2.24 4E-29 3.11 1E-03 0.92 3E-06  
Kif21a 2.24 1E-37 7.20 2E-14 1.80 4E-06  
Klf12 2.22 8E-06 23.62 3E-21 1.92 3E-07  
Pak6 2.22 8E-03 2.13 2E-03 1.69 3E-04  
Ddit4 2.19 5E-11 2.16 3E-04 0.91 1E-02  
Elmo1 2.18 3E-11 2.93 2E-06 0.88 8E-03  
Sorbs2os 2.17 9E-05 2.02 2E-16 1.14 2E-08  
Nov 2.16 2E-07 2.23 4E-03 3.01 2E-03  
Adamtsl1 2.16 1E-21 3.45 5E-05 2.06 3E-02  
Socs1 2.15 4E-12 4.64 1E-09 1.75 1E-07  
Sema6a 2.15 6E-14 18.00 2E-60 4.33 5E-05  
Galnt13 2.14 4E-07 5.87 4E-13 2.33 3E-05  
Tnfrsf1b 2.14 3E-18 1.93 3E-02 1.03 6E-06  
Elovl7 2.13 1E-04 7.16 1E-06 0.89 1E-02  
Macrod1 2.11 2E-12 1.68 2E-02 0.59 1E-03  
Insm1 2.10 2E-06 6.69 1E-12 4.41 3E-04  
Nav1 2.10 6E-37 1.92 2E-02 1.05 3E-03  
Msx3 2.10 2E-04 5.76 1E-17 6.50 1E-16  
Tcn2 2.09 2E-06 2.64 2E-06 1.99 6E-05  
Clip4 2.09 7E-26 8.94 2E-18 3.37 2E-15  
Apoh 2.09 7E-03 5.66 7E-17 1.60 4E-07  
Sox5 2.08 2E-13 22.06 6E-20 3.81 2E-03  
Eef2k 2.08 9E-22 1.90 9E-04 1.68 1E-08  
Slc7a7 2.07 9E-05 2.09 8E-08 0.92 1E-02  
Idua 2.05 1E-08 4.51 2E-03 1.84 3E-03  
Tspan11 2.04 1E-02 2.58 9E-08 1.79 3E-05  
Gfra2 2.02 2E-05 3.13 9E-09 1.44 3E-04  
Bin3 2.02 3E-26 3.11 1E-03 0.92 3E-06  
Kdm5d 2.02 5E-02 74.75 9E-31 6.69 2E-20  
Armc2 2.02 3E-05 11.22 1E-22 2.96 9E-11  
Laptm4b 2.01 2E-19 5.11 8E-05 1.24 4E-02  
Kcnn4 2.01 3E-02 2.15 4E-06 1.74 5E-08  
Uty 2.01 5E-02 121.18 8E-59 6.78 9E-18  
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Cdk6 2.01 7E-15 7.80 2E-07 2.20 1E-02  
Frmd4b 2.00 3E-19 4.34 1E-14 1.37 2E-05  
Sema5a 2.00 1E-21 6.62 3E-23 4.38 1E-05  
Lacc1 2.00 6E-22 2.60 4E-23 1.82 5E-03  
Lix1 1.99 5E-02 3.59 3E-09 1.15 7E-04  
Prr33 1.99 3E-05 2.91 4E-07 5.14 4E-82  
Tex26 1.99 2E-02 2.74 4E-05 0.45 3E-02  
Mr1 1.99 9E-14 3.18 3E-02 0.45 3E-02  
Fam92b 1.98 4E-02 3.28 8E-03 0.54 3E-02  
Slc25a30 1.96 3E-29 2.20 2E-02 1.69 8E-04  
Lemd1 1.95 2E-05 3.14 4E-05 0.68 5E-04  
Ank2 1.94 2E-21 4.22 7E-15 2.20 8E-06  
Arhgef37 1.94 6E-05 7.56 1E-21 2.34 2E-14  
Qrfpr 1.94 4E-03 3.28 6E-04 2.16 2E-04  
Rgs8 1.93 4E-14 6.96 9E-16 0.58 1E-02  
Map2 1.93 8E-23 5.28 5E-04 2.14 2E-03  
Gadd45a 1.93 9E-05 6.02 1E-05 1.55 1E-07  
Fam81a 1.92 2E-09 2.69 3E-05 1.40 9E-04  
M1ap 1.91 6E-04 1.98 2E-05 1.21 3E-02  
Adgrb1 1.91 4E-03 3.80 5E-04 2.53 9E-39  
Rab7b 1.89 5E-07 3.66 7E-11 0.75 2E-03  
Col14a1 1.88 3E-02 3.16 4E-07 0.69 4E-03  
Fmo5 1.87 6E-05 19.66 3E-29 1.73 1E-08  
Cdkn2b 1.87 7E-16 2.21 1E-10 1.97 2E-02  
Ccdc65 1.87 7E-06 3.18 4E-03 1.37 5E-12  
Gamt 1.87 2E-12 2.34 1E-03 1.53 7E-03  
Fgfbp1 1.86 2E-04 2.16 3E-03 1.23 1E-04  
Oaf 1.85 2E-09 13.88 4E-24 3.77 1E-12  
Madd 1.84 4E-24 2.94 1E-09 1.96 1E-07  
Syt13 1.84 2E-04 5.28 3E-25 1.93 6E-06  
Wnt5b 1.83 5E-03 3.15 3E-06 1.49 1E-10  
Cfap54 1.83 2E-08 2.35 5E-13 1.20 5E-06  
Aqp5 1.83 1E-06 3.86 7E-05 2.73 3E-30  
Inpp4b 1.82 2E-02 4.46 4E-05 0.96 1E-02  
Hacl1 1.82 9E-17 1.44 2E-05 0.51 8E-03  
Unc13c 1.82 2E-08 5.53 9E-05 1.63 1E-04  
Rnls 1.81 3E-06 4.30 1E-02 4.72 3E-06  
A730020E08Rik 1.80 5E-02 11.46 1E-22 1.99 6E-11  
Sh3kbp1 1.80 1E-23 3.85 1E-06 1.97 9E-03  
Gnpda1 1.80 5E-07 1.90 3E-05 2.05 1E-15  
Arhgap24 1.80 4E-09 3.67 2E-03 4.88 3E-07  
Tbx20 1.79 4E-07 2.51 6E-10 1.09 6E-07  
Camk1d 1.78 3E-23 4.82 1E-05 1.65 1E-02  
Serinc5 1.76 7E-20 15.13 3E-19 3.52 3E-17  
Tor3a 1.76 4E-17 1.96 2E-06 1.93 2E-09  
Ccser2 1.74 1E-36 8.00 1E-11 0.41 3E-02  
Map2k6 1.74 4E-07 2.35 1E-08 1.66 2E-04  
Tbx3 1.74 6E-12 11.38 4E-51 2.39 1E-19  
Eml1 1.73 5E-13 19.21 5E-28 4.82 2E-36  
Meis2 1.73 1E-26 3.61 4E-144 4.74 2E-14  
Dpp6 1.72 1E-02 16.62 5E-12 4.62 9E-06  
Nr1h5 1.72 5E-02 72.02 7E-29 3.18 4E-04  
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Lrrc7 1.70 3E-04 4.82 1E-05 2.13 2E-06  
Inpp5k 1.70 5E-21 3.59 2E-04 2.46 2E-07  
Pdzd7 1.69 1E-06 1.62 6E-03 0.79 4E-03  
Cdk19 1.69 2E-20 2.04 2E-03 1.81 2E-05  
Rai14 1.67 5E-29 3.49 6E-04 3.65 4E-05  
Calcoco1 1.66 4E-08 2.54 1E-08 0.94 2E-06  
Kalrn 1.66 1E-18 4.97 8E-18 1.09 4E-07  
Vax1 1.65 8E-08 10.83 2E-73 5.82 7E-49  
Apln 1.65 4E-08 2.20 6E-12 1.94 1E-02  
Zfp13 1.63 8E-08 2.75 4E-02 1.25 7E-04  
Dnm3 1.63 2E-02 2.85 4E-15 1.71 7E-09  
Epb41l4a 1.63 2E-25 24.40 1E-22 2.79 2E-03  
Rab3b 1.62 2E-06 20.51 3E-17 2.23 2E-16  
Pld2 1.61 6E-06 5.12 1E-14 2.28 2E-07  
Ropn1l 1.60 1E-04 8.12 2E-08 0.76 1E-02  
Pak1 1.60 4E-18 5.11 8E-05 2.26 2E-02  
Pde1b 1.59 5E-10 10.60 3E-10 4.61 1E-07  
Os9 1.59 2E-11 3.49 8E-13 1.34 1E-03  
Slc35b3 1.58 1E-12 2.39 9E-30 0.87 4E-03  
Atp2a3 1.58 3E-02 4.14 6E-03 4.73 1E-05  
Ociad2 1.57 2E-18 1.90 1E-03 1.87 2E-04  
Hs1bp3 1.57 5E-09 3.97 6E-03 1.16 1E-03  
Sox9 1.56 1E-07 2.21 1E-13 1.22 4E-04  
Akap6 1.56 7E-12 6.58 2E-88 4.36 1E-03  
Cryl1 1.56 5E-06 3.88 4E-03 1.38 1E-02  
Ttll7 1.55 2E-21 3.63 1E-03 2.81 2E-07  
Eno4 1.55 9E-04 2.19 1E-03 1.94 9E-03  
Nadk2 1.54 9E-14 11.57 4E-47 1.92 8E-04  
Eps8 1.54 9E-14 5.94 2E-15 2.63 3E-04  
Skap2 1.53 4E-10 23.62 3E-21 2.75 8E-08  
Tinagl1 1.52 6E-11 2.56 2E-02 1.01 6E-06  
Rapgef5 1.51 1E-05 3.67 2E-03 1.17 2E-03  
Fzd3 1.51 2E-13 4.13 1E-34 1.63 1E-02  
Adamtsl4 1.51 2E-07 3.83 2E-15 1.35 1E-08  
Adgrl3 1.51 4E-24 5.83 1E-14 3.07 2E-06  
Cbr2 1.50 2E-06 5.53 9E-05 3.59 2E-13  
Sorbs2 1.49 1E-27 2.02 2E-16 1.14 2E-08  
Stard13 1.48 6E-19 1.98 3E-21 1.83 4E-03  
Dcxr 1.47 8E-06 5.53 9E-05 3.59 2E-13  
Cngb1 1.47 5E-03 9.69 4E-08 1.84 2E-03  
Akap7 1.46 2E-13 2.54 8E-03 1.17 4E-02  
Apol6 1.46 8E-03 2.61 7E-04 2.37 8E-22  
Ank 1.46 9E-09 2.20 1E-07 1.14 1E-05  
Gabrb3 1.46 1E-02 3.51 6E-09 1.47 4E-03  
Mpzl1 1.46 1E-09 2.90 5E-03 2.18 9E-08  
Epm2a 1.45 2E-06 2.68 4E-08 0.73 3E-02  
Nanog 1.45 1E-03 2.99 4E-02 0.56 4E-02  
Bcas3 1.45 2E-09 7.71 5E-17 2.70 6E-03  
A930004D18Rik 1.44 9E-12 3.52 9E-36 1.16 6E-05  
Stk10 1.43 7E-08 2.40 2E-02 1.37 6E-05  
Lsp1 1.43 9E-07 2.91 4E-07 5.14 4E-82  
Rb1 1.42 2E-13 1.29 5E-04 3.21 7E-12  
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Synrg 1.42 5E-15 2.71 2E-02 1.30 1E-08  
Ptgfr 1.42 7E-04 2.98 3E-05 1.79 1E-02  
Bhlhe22 1.42 3E-04 3.50 1E-58 4.56 1E-12  
Rufy1 1.42 3E-24 3.23 9E-25 1.01 3E-02  
Litaf 1.42 9E-19 1.74 5E-05 1.10 3E-07  
Upp2 1.41 5E-04 2.41 1E-06 1.47 1E-03  
Mmp19 1.41 3E-04 2.49 4E-05 0.89 2E-04  
Pink1 1.40 4E-08 3.14 4E-05 1.60 2E-03  
Cp 1.40 2E-04 1.25 5E-03 1.77 1E-03  
Polm 1.39 6E-08 3.45 3E-12 2.21 1E-02  
Dlgap1 1.38 2E-02 1.39 1E-03 1.19 4E-09  
Osr1 1.38 2E-10 3.37 2E-04 3.92 1E-06  
St6gal1 1.37 2E-10 2.76 2E-05 0.69 2E-04  
Prkar1b 1.37 2E-03 12.41 2E-13 1.30 5E-04  
Rhobtb2 1.37 3E-07 4.32 6E-06 0.91 7E-03  
Aig1 1.36 8E-12 6.27 2E-06 2.11 1E-05  
Azin2 1.35 2E-06 3.11 7E-07 1.20 1E-06  
Irx3 1.35 1E-10 10.72 2E-20 5.95 2E-13  
Gsn 1.34 5E-09 2.53 6E-08 0.54 3E-02  
Ctnnd2 1.33 3E-06 2.64 3E-04 3.86 5E-03  
Tbc1d32 1.33 3E-18 3.50 4E-06 1.12 5E-03  
Mitf 1.33 7E-04 11.71 1E-23 1.30 2E-06  
Dubr 1.33 9E-06 9.53 8E-38 2.49 1E-17  
Pax9 1.32 1E-09 5.35 6E-29 2.60 2E-03  
Nemp2 1.32 2E-10 2.23 8E-03 1.37 3E-07  
Gm10125 1.31 4E-03 2.86 3E-04 1.13 5E-02  
Maml3 1.31 8E-08 3.08 2E-07 1.67 2E-12  
Tbccd1 1.31 2E-10 3.60 2E-06 1.75 4E-02  
Acaa2 1.31 6E-21 58.36 1E-21 4.76 1E-20  
Rorb 1.31 1E-08 8.33 4E-26 1.57 8E-13  
Kitl 1.30 1E-06 11.96 2E-12 1.53 2E-03  
Gramd4 1.28 6E-19 3.11 7E-07 0.64 1E-03  
Ift88 1.27 2E-10 2.12 1E-05 0.74 6E-05  
Il34 1.27 7E-05 4.25 4E-10 1.35 3E-07  
Scd2 1.26 3E-08 2.19 3E-06 0.90 1E-05  
Dok1 1.25 5E-08 1.98 2E-05 1.21 3E-02  
Ccser1 1.24 2E-04 11.46 1E-22 1.99 6E-11  
Klhl8 1.24 7E-09 1.88 5E-15 0.46 3E-02  
Ptprn2 1.24 2E-04 130.76 0E+00 8.23 2E-34  
Pccb 1.23 3E-10 4.61 9E-06 2.33 2E-03  
Nav3 1.23 5E-05 18.04 2E-37 1.89 7E-13  
Pacrg 1.22 3E-02 5.11 8E-05 2.00 2E-05  
Vamp4 1.22 1E-10 3.55 2E-29 2.19 2E-11  
Raph1 1.22 5E-14 2.98 3E-05 2.32 9E-04  
Ptgfrn 1.22 1E-11 7.76 1E-10 1.98 4E-10  
Hint3 1.22 1E-06 1.89 6E-03 2.17 1E-08  
Hbp1 1.22 8E-08 2.72 8E-28 1.83 3E-16  
Xrcc5 1.20 2E-13 2.93 3E-14 0.85 1E-02  
Dact2 1.18 1E-03 2.00 4E-03 0.58 9E-03  
Itgbl1 1.18 5E-02 1.66 2E-09 1.49 5E-04  
C030037D09Rik 1.18 2E-06 6.10 1E-17 2.60 1E-07  
Plvap 1.17 5E-05 3.05 7E-11 1.86 4E-04  
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Sesn1 1.17 3E-09 4.63 3E-14 2.80 2E-09  
Sptbn2 1.17 1E-02 3.84 1E-07 0.84 1E-02  
Pibf1 1.16 2E-08 2.26 2E-06 3.24 6E-08  
Gm16596 1.16 4E-02 3.94 6E-20 2.27 2E-10  
Gpalpp1 1.16 3E-16 5.33 4E-07 3.02 2E-07  
Lipa 1.14 9E-09 4.62 5E-15 1.31 4E-02  
Sbno2 1.14 6E-09 2.18 3E-09 1.52 3E-13  
Pthlh 1.14 3E-02 6.77 1E-38 5.51 7E-11  
Mccc1 1.14 2E-07 2.16 2E-03 3.02 3E-04  
Abr 1.14 2E-15 3.34 1E-06 1.82 2E-17  
Syne2 1.14 3E-06 88.41 2E-38 2.69 1E-05  
Lef1 1.13 1E-04 2.36 4E-07 0.57 2E-02  
Kat6b 1.13 8E-10 4.13 1E-21 1.34 4E-02  
Ctdsp2 1.13 1E-09 3.11 2E-10 1.68 1E-06  
Tshz1 1.12 3E-17 8.58 8E-57 2.00 1E-07  
Cerk 1.12 3E-05 3.11 7E-07 0.64 1E-03  
Marcks 1.12 3E-04 5.53 9E-05 0.67 1E-02  
Sugt1 1.12 2E-19 15.80 4E-30 2.41 6E-05  
Trib2 1.11 8E-05 2.74 2E-04 1.42 2E-02  
Tcf4 1.11 3E-13 1.38 3E-04 0.56 8E-03  
Cyb5r3 1.10 7E-08 2.36 2E-03 0.61 8E-03  
Tspan14 1.10 3E-09 2.14 1E-03 0.83 1E-04  
Lhx9 1.09 2E-05 3.13 7E-05 2.20 5E-07  
Zfyve26 1.09 2E-09 2.46 2E-07 1.19 2E-03  
Ntn4 1.09 9E-09 2.11 1E-03 0.71 3E-02  
Slit3 1.09 9E-05 2.74 4E-05 0.55 8E-03  
Mtss1 1.08 2E-06 4.99 2E-06 2.54 1E-18  
Daam1 1.08 2E-19 2.35 1E-04 2.36 2E-07  
Zhx2 1.07 3E-10 80.21 1E-34 2.55 3E-14  
Aqp11 1.07 2E-02 3.59 2E-04 1.38 3E-08  
Psap 1.07 2E-08 3.10 6E-03 1.06 3E-02  
Zfp286 1.07 6E-05 5.84 2E-09 0.88 5E-04  
Limk2 1.06 1E-07 1.68 4E-02 0.96 2E-03  
Sox21 1.06 2E-05 1.62 6E-03 1.42 5E-13  
Lta4h 1.05 2E-19 2.39 3E-05 1.51 8E-07  
Rab36 1.05 3E-04 2.23 4E-06 0.77 3E-05  
Mecom 1.05 4E-05 5.11 8E-05 3.23 2E-07  
Tsc22d3 1.05 1E-05 3.80 5E-04 2.68 8E-03  
Rab32 1.04 7E-06 4.41 2E-11 1.44 2E-02  
Pcnx 1.04 1E-10 3.03 3E-03 1.31 1E-02  
Btg1 1.04 5E-05 3.43 2E-09 2.84 3E-26  
Rabggta 1.04 3E-10 3.35 2E-13 1.15 1E-02  
Pnpo 1.04 2E-02 2.10 6E-09 0.86 4E-05  
Zadh2 1.03 3E-10 1.57 4E-03 0.72 5E-03  
Foxc2 1.03 7E-07 3.18 4E-03 2.66 3E-25  
Lrig3 1.03 3E-10 2.90 1E-51 2.56 9E-05  
Rnaseh2b 1.01 1E-06 7.67 1E-28 5.44 9E-12  
Rap1gap2 1.01 1E-06 17.40 3E-13 1.79 4E-02  
Kif16b 1.01 9E-08 5.04 3E-03 0.88 4E-02  
Ttc23 1.01 7E-12 6.52 7E-05 2.28 6E-07  
Agpat3 1.01 9E-10 7.16 1E-06 0.93 5E-03  
Trim66 1.00 2E-02 2.93 7E-08 2.36 8E-08  
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Sh3pxd2b 1.00 2E-06 2.93 2E-02 0.80 1E-03  
Fbxo16 1.00 9E-03 7.80 2E-07 1.40 5E-03  
Pcolce2 0.99 2E-07 2.66 1E-11 3.89 8E-24  
Slc16a7 0.99 8E-04 8.33 1E-15 0.95 2E-04  
Bach2 0.98 5E-05 5.05 3E-22 1.32 3E-03  
Pter 0.98 9E-09 2.39 1E-35 2.39 2E-03  
Osbpl6 0.98 5E-08 46.42 6E-102 5.61 4E-12  
Syn1 0.98 8E-03 1.96 4E-22 1.10 3E-02  
Zbtb20 0.97 1E-05 1.93 8E-09 0.65 2E-03  
Arrdc3 0.97 2E-07 8.73 1E-21 0.70 3E-02  
C430049B03Rik 0.97 1E-02 3.27 2E-05 2.77 2E-09  
Tnfaip8 0.97 6E-11 2.88 2E-07 1.99 2E-05  
Arhgap18 0.97 7E-05 2.63 1E-03 3.65 1E-04  
Cacnb2 0.97 2E-09 4.65 6E-05 1.60 2E-02  
Cd47 0.96 2E-06 2.56 2E-03 1.44 1E-02  
Sirt5 0.96 1E-04 5.04 3E-03 4.34 3E-05  
Decr1 0.96 1E-05 8.87 9E-26 3.75 2E-06  
Borcs6 0.96 8E-06 5.38 7E-17 4.40 1E-09  
Arid5b 0.96 4E-08 1.60 3E-02 2.06 2E-02  
Fbln1 0.96 1E-03 5.85 2E-18 0.74 3E-02  
Ndst3 0.95 6E-04 5.64 4E-10 0.89 1E-02  
Cpq 0.95 4E-04 5.04 3E-03 4.03 4E-08  
Cog3 0.95 9E-12 2.20 2E-02 1.69 8E-04  
Cbr4 0.94 7E-07 3.07 1E-04 0.80 1E-03  
Wasf1 0.93 7E-05 6.77 5E-08 2.01 1E-04  
Lrp10 0.93 5E-06 1.86 3E-02 0.62 3E-03  
Zscan2 0.93 7E-03 1.42 2E-02 0.49 2E-02  
Eva1c 0.92 4E-08 2.42 6E-16 0.64 1E-03  
Prcp 0.92 2E-10 4.20 1E-12 1.35 2E-02  
Bbs10 0.92 7E-04 2.65 8E-05 1.04 5E-02  
Cbx7 0.92 1E-03 1.72 1E-02 1.87 2E-02  
Cfap61 0.92 2E-02 2.05 3E-20 1.47 5E-10  
Cyp46a1 0.92 2E-02 4.90 1E-24 4.05 3E-27  
Sms 0.91 2E-02 2.28 7E-05 1.58 1E-03  
Btc 0.91 1E-02 2.11 1E-06 1.38 4E-02  
Cdc40 0.90 9E-10 4.97 1E-08 1.75 4E-03  
Perp 0.89 2E-03 5.49 7E-11 0.96 2E-02  
Abcc4 0.89 2E-06 6.52 7E-05 2.25 7E-05  
Nox4 0.89 2E-07 4.30 1E-02 0.95 4E-03  
Ebf1 0.89 7E-05 2.16 2E-02 1.23 4E-07  
Zfp827 0.88 3E-06 3.07 3E-02 1.69 5E-03  
Msi2 0.88 7E-08 6.10 1E-17 2.60 1E-07  
Spata13 0.88 1E-04 15.84 8E-11 2.43 2E-12  
Skida1 0.87 3E-06 1.60 6E-19 1.97 2E-15  
Runx3 0.87 2E-02 3.19 2E-03 3.04 2E-38  
Cpne8 0.86 2E-06 3.05 1E-10 1.00 6E-03  
Mtss1l 0.86 1E-02 4.25 4E-10 1.35 3E-07  
Mbtd1 0.86 4E-04 2.94 8E-07 1.61 7E-05  
Spry2 0.86 1E-10 4.24 3E-09 0.65 1E-02  
Yeats4 0.86 3E-10 4.07 3E-15 1.65 2E-03  
Slc29a3 0.85 9E-06 4.38 2E-22 1.74 2E-11  
Wdr59 0.85 2E-09 5.13 7E-11 1.14 3E-02  
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Pcyt1b 0.85 4E-04 3.12 1E-07 2.25 4E-04  
Ralgapa2 0.85 2E-07 4.97 7E-27 1.56 1E-06  
B130024G19Rik 0.85 3E-02 2.88 2E-10 1.81 9E-03  
Fam181b 0.85 4E-02 4.20 1E-12 1.35 2E-02  
Gmds 0.85 2E-09 2.90 2E-05 0.88 5E-02  
Usp53 0.85 4E-04 1.96 7E-05 2.36 2E-02  
Mtmr9 0.84 3E-07 4.09 2E-09 0.92 3E-05  
Apobec3 0.84 1E-04 1.72 1E-02 1.87 2E-02  
Bcr 0.84 6E-07 12.86 1E-14 1.00 7E-09  
Mid2 0.84 9E-09 3.28 1E-02 2.68 8E-03  
Heatr5a 0.83 1E-05 4.46 4E-05 2.15 2E-02  
Micu1 0.83 1E-06 1.54 2E-05 1.62 3E-08  
Stx8 0.83 3E-06 85.68 1E-36 1.57 9E-12  
Epdr1 0.83 5E-05 2.22 1E-03 1.31 9E-03  
Poli 0.83 2E-05 2.17 4E-09 1.19 4E-07  
Arntl 0.83 8E-07 5.31 1E-05 3.18 3E-13  
Ttc33 0.82 3E-08 2.56 2E-04 3.31 2E-12  
Sfxn3 0.82 2E-04 1.62 6E-03 0.79 4E-03  
Nufip1 0.82 2E-05 5.33 4E-07 3.02 2E-07  
Slc35e3 0.81 2E-02 1.59 2E-08 0.94 3E-02  
Tob1 0.81 2E-04 3.02 6E-05 1.56 1E-07  
L3mbtl3 0.81 2E-09 2.68 7E-11 0.71 3E-02  
Myo1e 0.80 4E-07 2.69 3E-05 1.40 9E-04  
Pou3f3 0.80 7E-04 1.43 1E-15 0.76 5E-03  
Dap 0.79 6E-03 1.99 6E-05 1.66 6E-04  
Narf 0.79 7E-05 2.61 3E-02 0.89 4E-02  
Akr1e1 0.79 1E-04 3.53 3E-21 2.59 8E-03  
Suox 0.79 1E-03 9.46 1E-28 1.18 5E-04  
Angptl2 0.79 8E-05 3.55 3E-17 0.78 1E-02  
Snx13 0.79 2E-07 2.73 1E-07 1.38 2E-05  
Frs2 0.79 8E-09 2.46 2E-53 1.04 3E-03  
Slc7a11 0.79 5E-03 1.71 8E-03 0.87 4E-02  
Trps1 0.78 6E-07 3.09 1E-02 0.71 7E-03  
Fryl 0.78 5E-09 5.28 5E-04 1.44 5E-06  
Casp6 0.78 3E-07 2.42 3E-02 4.02 6E-07  
Gtf2f2 0.78 8E-06 6.27 2E-06 0.84 3E-02  
Cyb561d1 0.77 6E-03 4.14 9E-08 1.14 2E-03  
Elf1 0.77 2E-06 15.80 4E-30 2.41 6E-05  
Lcmt1 0.77 5E-07 5.16 2E-12 1.47 7E-06  
Cacna1a 0.77 2E-03 2.34 2E-02 1.72 5E-22  
Mink1 0.76 2E-04 5.12 1E-14 2.28 2E-07  
Zfp68 0.76 8E-05 1.96 1E-02 2.23 6E-03  
Mapk1ip1l 0.76 4E-07 1.57 5E-02 1.62 4E-07  
Mkrn1 0.76 7E-05 4.82 1E-05 1.18 1E-03  
Akap17b 0.75 8E-04 2.52 3E-02 1.20 3E-03  
Epb41l2 0.74 2E-07 3.27 2E-06 1.53 7E-07  
Irf2bpl 0.74 2E-04 3.94 1E-26 3.45 9E-08  
Fnip1 0.74 1E-03 11.05 3E-10 1.15 1E-02  
Tm4sf1 0.74 2E-02 1.64 4E-29 4.78 5E-10  
Pam 0.74 2E-06 2.56 2E-04 2.75 3E-03  
Ube2b 0.74 6E-05 5.56 1E-17 3.49 2E-09  
Clip3 0.73 1E-02 6.52 7E-05 0.55 5E-02  
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Mapre3 0.73 8E-03 1.60 2E-02 0.78 9E-03  
Gdnf 0.73 5E-04 5.85 7E-56 1.81 9E-03  
Radil 0.73 3E-03 2.09 7E-04 1.84 2E-17  
Hexb 0.73 1E-02 3.19 2E-03 1.71 6E-10  
Rab5b 0.73 4E-03 9.46 1E-28 1.18 5E-04  
Cd9 0.73 1E-06 5.16 2E-06 1.81 4E-10  
Lama5 0.73 6E-06 2.11 1E-03 0.88 4E-05  
Arf6 0.72 3E-05 1.54 4E-02 0.52 1E-02  
Ptger4 0.72 1E-02 3.27 8E-10 0.99 6E-04  
Xkr6 0.71 6E-04 20.62 3E-73 3.90 7E-22  
Nid2 0.71 6E-04 2.27 4E-05 0.95 3E-02  
Spag9 0.71 3E-06 3.02 6E-05 1.56 1E-07  
Wbp4 0.71 3E-06 2.94 1E-13 2.95 3E-07  
Enpp5 0.71 4E-02 1.74 8E-04 0.76 7E-03  
Bmper 0.70 2E-02 3.50 1E-51 2.10 2E-08  
Fnip2 0.70 3E-04 6.23 2E-12 5.58 4E-28  
Msra 0.70 3E-03 5.53 9E-05 1.80 1E-03  
Mkl2 0.70 5E-04 11.96 2E-12 1.09 3E-03  
Lif 0.69 2E-02 7.26 9E-10 1.55 5E-08  
Dtd2 0.69 4E-04 4.46 4E-05 2.15 2E-02  
Pttg1ip 0.69 7E-06 2.49 2E-02 1.18 5E-03  
Cyb5a 0.69 8E-06 1.91 2E-10 0.71 5E-02  
Notch2 0.68 5E-07 1.73 6E-06 1.37 3E-03  
Prdm16 0.68 3E-03 10.72 4E-57 2.08 1E-20  
Sh3pxd2a 0.68 1E-03 4.91 4E-04 1.95 2E-16  
Unc119 0.67 2E-02 2.19 3E-06 1.69 5E-20  
Tom1l2 0.67 3E-03 4.79 9E-09 0.58 4E-02  
Mrpl52 0.67 3E-03 2.09 8E-08 0.92 1E-02  
Acot13 0.67 4E-04 5.12 3E-58 1.77 5E-07  
Vta1 0.67 2E-06 4.91 4E-04 2.03 4E-04  
Sipa1l2 0.66 2E-04 3.37 1E-03 1.80 2E-15  
Prex2 0.66 6E-04 3.73 1E-02 0.89 8E-04  
Amigo1 0.66 5E-02 4.14 9E-08 1.14 2E-03  
Zeb1 0.66 2E-06 2.86 3E-04 1.13 5E-02  
Bbs9 0.65 7E-03 3.68 5E-07 2.69 2E-05  
Ghitm 0.65 3E-07 2.48 6E-09 0.41 3E-02  
Itpkb 0.65 2E-02 9.69 4E-08 1.40 5E-05  
Mxi1 0.65 1E-04 3.28 1E-02 3.27 9E-08  
Abhd2 0.65 1E-04 2.85 3E-11 2.47 7E-09  
Ric8b 0.65 2E-06 23.62 3E-21 1.83 4E-06  
Wwc1 0.65 8E-04 3.47 9E-27 3.11 1E-03  
Shroom4 0.64 2E-05 3.02 3E-16 1.64 4E-02  
Plekha7 0.64 6E-03 3.45 2E-08 1.48 7E-13  
Lnpep 0.64 1E-06 3.59 3E-09 1.15 7E-04  
Vcpkmt 0.63 1E-02 2.06 1E-14 0.54 5E-03  
Tbce 0.63 5E-04 2.82 1E-04 1.43 3E-04  
Hdac5 0.63 3E-03 2.61 1E-09 0.46 2E-02  
Plekhb2 0.62 2E-04 20.19 1E-98 3.68 2E-42  
Llgl1 0.62 7E-03 3.28 1E-03 1.41 1E-03  
Cdh13 0.61 8E-04 3.12 9E-11 1.64 1E-15  
Trim45 0.61 4E-03 3.11 1E-03 1.17 4E-02  
Nprl3 0.61 2E-04 2.96 3E-13 1.73 4E-05  
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Plekha5 0.61 1E-04 2.39 7E-11 5.26 7E-10  
Pyurf 0.61 1E-03 4.12 6E-16 1.77 5E-07  
Sil1 0.61 2E-04 3.16 2E-31 1.99 1E-08  
Cacnb3 0.60 2E-03 2.33 3E-04 1.71 2E-11  
Runx2 0.59 6E-03 4.09 6E-21 2.63 9E-03  
Sdccag8 0.59 7E-04 10.22 8E-43 3.28 5E-10  
Xpo7 0.59 3E-03 4.02 9E-04 1.14 3E-03  
Nceh1 0.59 4E-04 4.46 4E-05 3.66 8E-11  
Ugp2 0.58 6E-04 2.43 3E-05 1.21 4E-02  
Slc17a5 0.57 9E-03 2.71 4E-03 2.72 5E-33  
Asap1 0.57 2E-04 3.34 9E-15 1.05 3E-08  
Avpi1 0.57 2E-03 1.68 1E-03 0.94 1E-04  
Sgms2 0.56 2E-04 2.28 5E-09 0.72 7E-03  
Fibp 0.56 3E-03 1.73 3E-03 1.16 3E-05  
Sgpl1 0.56 1E-04 2.73 6E-07 1.24 7E-04  
St3gal4 0.56 4E-04 3.80 3E-02 0.79 2E-05  
Zfyve21 0.55 9E-04 5.23 4E-10 1.25 3E-02  
Aldh3a2 0.55 2E-04 7.84 3E-20 0.77 7E-03  
Rreb1 0.55 7E-03 3.88 4E-09 2.87 1E-05  
Dbnl 0.55 1E-02 18.30 1E-26 1.69 3E-07  
Map3k13 0.55 1E-02 8.74 1E-17 1.53 1E-06  
Ndfip2 0.54 2E-04 2.56 2E-02 1.41 7E-11  
Wdr7 0.54 3E-04 7.80 2E-07 0.86 3E-02  
Ccdc6 0.54 3E-03 2.14 2E-05 0.93 2E-03  
Flii 0.54 9E-05 3.28 1E-03 1.41 1E-03  
Pdxk 0.52 1E-02 2.35 4E-02 0.88 1E-06  
Fam172a 0.52 9E-04 2.82 1E-04 0.95 1E-02  
Kat7 0.51 5E-04 4.76 2E-06 1.21 7E-03  
Akt3 0.51 3E-03 7.56 1E-24 3.28 5E-10  
Fundc1 0.51 3E-03 2.47 2E-07 1.58 7E-05  
Adck2 0.50 3E-02 2.54 8E-03 2.16 4E-06  
Lancl2 0.50 2E-02 4.12 6E-16 1.77 5E-07  
Prps1l3 0.50 7E-03 3.14 2E-14 1.48 2E-16  
Heca 0.50 7E-03 3.37 1E-03 2.22 6E-03  
Rnf32 0.49 3E-03 2.37 3E-04 1.59 2E-12  
Btd 0.49 2E-02 1.46 6E-04 0.51 8E-03  
Prkca 0.49 2E-03 5.66 7E-17 1.60 4E-07  
Ube2e2 0.49 2E-03 3.10 3E-12 0.81 3E-02  
Epn2 0.48 5E-03 5.13 7E-11 3.60 1E-04  
Gab1 0.48 3E-02 2.18 2E-11 1.20 3E-03  
Rab30 0.48 2E-03 1.81 4E-05 1.54 1E-03  
Atxn10 0.48 2E-04 3.19 8E-47 5.06 3E-12  
Kdm4a 0.48 4E-03 5.82 6E-20 4.30 4E-09  
Nln 0.47 4E-04 1.75 4E-03 1.39 1E-11  
Utrn 0.47 7E-04 2.05 7E-13 2.80 2E-05  
Rapgef6 0.47 2E-02 11.05 3E-10 1.15 1E-02  
Fam114a2 0.46 5E-03 5.95 3E-19 2.16 7E-20  
Klf10 0.46 4E-03 3.73 1E-02 1.84 4E-04  
Lrrc28 0.46 3E-02 6.52 7E-05 2.28 6E-07  
Akap11 0.46 6E-03 2.51 2E-20 0.91 2E-03  
Dnajc7 0.46 8E-04 5.58 1E-14 1.15 8E-05  
Pbx1 0.46 1E-02 4.32 9E-07 1.13 2E-06  
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Commd1 0.46 3E-02 3.58 1E-06 1.78 2E-07  
Cant1 0.45 2E-02 4.46 4E-05 1.03 3E-07  
Ghr 0.45 3E-02 2.23 8E-03 1.56 7E-03  
Pvt1 0.45 3E-02 2.71 6E-05 1.51 3E-08  
Tns3 0.45 3E-02 2.63 1E-03 1.17 1E-06  
Mcu 0.45 4E-02 1.54 2E-05 1.62 3E-08  
Sec63 0.45 2E-03 2.21 4E-16 3.96 1E-08  
Ppp3ca 0.45 9E-04 2.55 5E-14 2.02 7E-07  
Sh2b3 0.44 4E-02 4.99 2E-06 1.70 2E-03  
Specc1l 0.44 1E-03 12.86 1E-14 1.00 7E-09  
Pde3b 0.44 1E-03 19.73 7E-16 1.35 1E-02  
Trim16 0.44 3E-02 5.84 2E-09 0.88 5E-04  
Atg7 0.44 1E-02 1.68 9E-05 1.27 2E-08  
Nf1 0.44 7E-03 2.33 1E-02 2.90 3E-09  
Fgd6 0.44 5E-03 7.48 2E-07 2.59 5E-04  
Chmp6 0.43 5E-02 1.76 4E-03 1.50 2E-04  
Fto 0.43 5E-02 10.72 2E-20 5.95 2E-13  
Arid1b 0.43 4E-02 9.34 2E-19 1.75 3E-11  
Lrp6 0.43 2E-03 4.61 9E-06 2.30 2E-10  
Osbpl8 0.43 2E-02 2.46 7E-04 1.82 2E-04  
Nrp1 0.42 1E-02 2.10 3E-02 0.78 4E-02  
Tbcc 0.42 2E-02 2.37 7E-07 0.59 1E-02  
Terf2 0.42 1E-02 4.33 1E-10 0.81 4E-02  
Atg101 0.42 2E-02 2.15 2E-10 1.09 7E-06  
Rabl3 0.42 3E-02 4.51 2E-03 2.31 1E-02  
Klhl22 0.42 5E-02 5.02 4E-10 1.24 9E-06  
Samd4 0.41 9E-03 3.21 2E-15 3.49 5E-05  
Dym 0.41 2E-02 2.95 1E-02 1.24 2E-03  
Sort1 0.41 5E-02 2.03 5E-04 2.06 3E-20  
Stim2 0.41 3E-02 2.97 3E-34 0.56 1E-02  
Rims2 0.40 2E-02 5.95 3E-19 3.45 2E-05  
Tmem164 0.40 3E-02 3.73 1E-02 2.02 5E-02  
Mon2 0.40 9E-04 1.89 5E-16 1.04 2E-03  
Plekhh2 0.40 1E-02 2.58 3E-16 1.78 2E-09  
Inf2 0.40 3E-02 4.99 2E-06 0.67 2E-03  
Papolg 0.40 2E-02 16.62 5E-12 4.83 2E-13  
Tmem2 0.40 2E-03 2.87 5E-08 1.21 1E-03  
Nr2f2 0.40 3E-02 1.88 8E-30 1.07 5E-09  
Jarid2 0.38 2E-02 3.63 1E-05 1.02 2E-03  
Rnh1 0.38 3E-03 1.83 4E-02 0.61 2E-02  
Fbxo4 0.37 2E-02 2.38 9E-03 0.88 3E-05  
Dock5 0.37 2E-02 5.84 2E-09 0.54 2E-02  
Btbd3 0.37 4E-03 3.58 2E-13 2.64 1E-11  
Abl2 0.37 3E-02 1.68 5E-06 1.18 3E-03  
Ppp1r12a 0.36 2E-02 2.52 3E-02 1.21 4E-02  
Smad5 0.35 3E-02 29.06 7E-30 0.93 9E-04  
Dnajb12 0.35 5E-02 2.16 3E-04 0.91 1E-02  
Osbpl3 0.34 5E-02 2.50 1E-05 1.06 4E-02  
Zc3h14 0.34 2E-02 2.47 3E-02 0.71 5E-04  
Ifngr1 0.33 3E-02 12.60 9E-21 4.09 1E-08  
Slc35d1 0.33 4E-02 2.47 3E-02 0.94 7E-03  
Exoc4 0.33 2E-02 2.80 8E-04 1.81 9E-06  
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Ctnna1 0.32 2E-02 3.16 2E-31 1.99 1E-08  
Camsap2 0.32 3E-02 3.12 5E-04 1.81 3E-03  
Ak5 0.32 4E-02 1.89 2E-03 1.92 2E-02  
Anxa5 0.32 8E-03 3.06 3E-09 0.95 5E-03  
Exoc6b 0.32 4E-02 4.91 4E-04 1.86 1E-04  
Oxr1 0.32 4E-02 5.67 1E-08 4.08 3E-05  
Ino80c 0.31 5E-02 4.02 9E-04 1.59 4E-03  
Tab2 0.30 5E-02 14.68 4E-18 2.15 4E-15  
Nav2 0.30 3E-02 2.33 1E-02 1.43 2E-07  
Dync1i2 0.28 3E-02 3.62 8E-39 1.83 1E-02  
Zc2hc1a -0.26 5E-02 0.13 1E-08 -5.68 8E-15  
Tbc1d1 -0.28 4E-02 0.38 2E-05 -2.66 2E-07  
Rnf111 -0.28 5E-02 0.22 8E-03 -1.92 3E-07  
Sub1 -0.29 4E-02 0.01 2E-48 -6.85 4E-22  
Abcd3 -0.29 4E-02 0.69 2E-02 -1.27 1E-03  
Trim56 -0.30 2E-02 0.41 7E-09 -1.34 3E-04  
Nbea -0.31 3E-02 0.30 3E-07 -2.35 8E-03  
Golph3 -0.31 5E-02 0.21 3E-04 -4.46 4E-06  
Dnajc13 -0.31 3E-02 0.10 1E-09 -2.18 1E-05  
Crk -0.31 4E-02 0.21 3E-04 -1.16 5E-02  
Parg -0.31 3E-02 0.11 2E-15 -1.99 1E-05  
Cdyl -0.32 5E-02 0.10 2E-19 -1.51 3E-05  
Sp3 -0.32 2E-02 0.53 7E-03 -3.89 2E-04  
Igf1r -0.32 3E-02 0.21 5E-07 -1.84 5E-09  
Tapt1 -0.32 2E-02 0.25 3E-02 -5.72 6E-13  
Map3k7 -0.33 8E-03 0.34 2E-16 -1.84 4E-09  
Fam49b -0.36 5E-02 0.34 2E-04 -2.17 2E-04  
Pgrmc2 -0.36 2E-02 0.16 1E-11 -3.03 2E-21  
Wwp1 -0.37 6E-03 0.22 9E-15 -1.94 1E-08  
Mpdz -0.37 3E-02 0.36 9E-03 -5.36 5E-10  
Slmap -0.37 2E-02 0.40 3E-12 -4.54 9E-06  
Dhx30 -0.38 3E-02 0.44 4E-04 -5.11 4E-09  
Six4 -0.38 2E-02 0.40 2E-10 -1.15 2E-04  
Edrf1 -0.38 3E-02 0.01 2E-38 -3.77 5E-07  
Mcc -0.38 1E-02 0.48 2E-02 -1.76 6E-04  
Pi4k2b -0.39 5E-02 0.46 5E-04 -0.56 4E-03  
Cops8 -0.39 3E-02 0.24 8E-06 -1.63 1E-02  
Skil -0.40 5E-02 0.50 3E-07 -1.71 1E-03  
Ikzf2 -0.40 2E-02 0.17 1E-27 -3.08 2E-11  
Esyt2 -0.40 8E-03 0.20 7E-10 -1.83 2E-02  
Nup88 -0.40 3E-02 0.09 1E-10 -1.35 6E-03  
Aco1 -0.40 4E-02 0.40 2E-09 -1.32 3E-02  
Tmed8 -0.40 1E-02 0.21 6E-05 -0.85 5E-03  
Uggt1 -0.40 2E-02 0.06 1E-11 -1.92 2E-02  
Vps13a -0.40 4E-02 0.28 4E-04 -2.39 1E-10  
Prdm15 -0.41 2E-02 0.40 5E-04 -1.25 9E-04  
Snx25 -0.41 2E-02 0.38 2E-12 -1.86 6E-03  
Irak1bp1 -0.41 2E-02 0.47 4E-07 -4.09 1E-04  
Fam120a -0.41 2E-02 0.33 7E-08 -1.38 3E-02  
Mttp -0.42 5E-02 0.45 5E-08 -0.48 2E-02  
Pomp -0.42 2E-02 0.16 7E-11 -5.94 5E-14  
Nepro -0.43 2E-02 0.03 3E-69 -4.22 6E-10  
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Bhlhb9 -0.43 5E-03 0.04 5E-22 -2.62 7E-08  
Me1 -0.44 7E-03 0.05 6E-18 -1.41 7E-05  
Maea -0.44 1E-02 0.09 1E-10 -1.39 1E-05  
Smg7 -0.44 6E-04 0.50 1E-03 -0.99 3E-03  
Trmt5 -0.44 1E-02 0.46 1E-10 -2.49 3E-03  
Ubr3 -0.45 2E-03 0.24 7E-03 -2.98 1E-22  
Tbc1d12 -0.45 1E-02 0.23 3E-04 -2.94 4E-07  
Polr2m -0.45 4E-03 0.31 6E-06 -1.92 2E-04  
Slx4ip -0.45 2E-02 0.01 1E-34 -3.24 2E-18  
Gng12 -0.46 3E-04 0.01 7E-29 -3.36 1E-06  
Cdh2 -0.46 2E-04 0.50 8E-09 -4.92 9E-08  
Itpr1 -0.46 2E-02 0.07 3E-09 -1.56 7E-10  
Kifap3 -0.46 2E-03 0.13 1E-08 -2.83 9E-03  
Slc25a13 -0.46 3E-02 0.08 5E-69 -2.33 3E-04  
Fbxo33 -0.47 6E-03 0.16 2E-04 -0.72 3E-02  
Zbtb2 -0.47 3E-02 0.58 7E-03 -2.41 2E-06  
Fndc3b -0.47 1E-03 0.33 3E-03 -1.38 9E-12  
Atrn -0.47 8E-04 0.25 6E-06 -0.85 4E-02  
Naa10 -0.48 4E-02 0.11 1E-06 -1.32 2E-06  
Api5 -0.48 2E-02 0.02 9E-20 -3.87 6E-04  
Armc8 -0.48 6E-04 0.14 6E-07 -1.05 3E-03  
Zcchc2 -0.48 2E-03 0.01 2E-44 -1.37 4E-05  
Rtfdc1 -0.49 5E-04 0.22 6E-12 -1.21 3E-02  
Braf -0.49 3E-04 0.24 2E-11 -2.94 2E-02  
Mgat5 -0.50 1E-02 0.10 2E-18 -1 1E-03  
Sec61a1 -0.50 3E-04 0.22 7E-10 -1.27 1E-05  
Scaf4 -0.50 2E-02 0.35 7E-10 -1.52 2E-07  
Cenpc1 -0.51 9E-03 0.43 6E-03 -1.83 1E-04  
Snx18 -0.51 5E-03 0.43 1E-07 -3.08 2E-03  
Fstl1 -0.51 1E-04 0.29 8E-03 -1.15 3E-02  
Jade1 -0.51 5E-02 0.07 1E-27 -3.72 4E-05  
Nfib -0.51 2E-03 0.29 1E-74 -3.41 1E-08  
Ptprk -0.52 5E-04 0.27 6E-04 -2.7 1E-03  
Fosl2 -0.53 6E-03 0.43 3E-03 -3.02 1E-11  
Rnf6 -0.53 2E-04 0.35 3E-05 -2.28 4E-07  
Bnip2 -0.53 8E-04 0.08 2E-47 -4.65 2E-05  
Pdzd8 -0.55 6E-04 0.65 2E-06 -0.68 1E-03  
Mto1 -0.56 3E-03 0.25 2E-04 -1.78 7E-12  
Ksr1 -0.56 4E-02 0.12 1E-09 -1.84 8E-10  
Dennd1a -0.57 2E-02 0.16 2E-07 -1.67 5E-05  
Mllt3 -0.57 9E-05 0.23 2E-06 -3.58 5E-04  
Mavs -0.57 5E-03 0.29 5E-06 -2.52 1E-04  
Srfbp1 -0.57 4E-03 0.52 4E-05 -2.05 2E-08  
Hdac4 -0.57 1E-04 0.15 2E-29 -1.5 2E-04  
Ablim1 -0.58 1E-02 0.02 9E-20 -6.33 6E-16  
Inip -0.58 9E-03 0.21 7E-10 -5.34 2E-10  
Map2k1 -0.59 1E-05 0.14 7E-16 -5.29 2E-25  
Clpb -0.59 6E-03 0.22 1E-10 -1.21 2E-04  
Chordc1 -0.59 2E-04 0.01 9E-31 -1.08 2E-02  
Nsun2 -0.59 4E-02 0.29 5E-02 -2.51 1E-04  
Ppp6c -0.60 2E-06 0.45 6E-03 -2.98 1E-10  
Mrps28 -0.60 5E-03 0.27 5E-07 -0.9 1E-03  
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Prtg -0.60 3E-04 0.08 8E-13 -0.96 1E-07  
Prss23 -0.60 5E-03 0.47 5E-02 -2.56 6E-04  
Etv6 -0.60 2E-04 0.25 2E-04 -1.43 9E-05  
D5Ertd579e -0.60 8E-06 0.31 2E-02 -1.21 2E-03  
Mrps6 -0.61 1E-05 0.45 2E-02 -2.52 2E-04  
Usp47 -0.61 1E-05 0.05 7E-49 -6.4 7E-17  
Cxxc5 -0.62 5E-03 0.23 9E-20 -0.73 5E-02  
Slc25a28 -0.62 8E-05 0.29 8E-03 -1.53 8E-05  
Arpp19 -0.62 1E-05 0.12 1E-38 -1.68 4E-06  
Hdac9 -0.62 2E-02 0.26 1E-15 -1.94 7E-04  
Gle1 -0.62 5E-04 0.61 7E-03 -1.42 4E-03  
Senp5 -0.63 2E-04 0.01 1E-32 -2.04 8E-04  
Setbp1 -0.63 3E-06 0.31 6E-05 -1.42 3E-02  
Lzic -0.63 3E-06 0.23 1E-08 -1.23 5E-03  
Tmem70 -0.64 3E-04 0.07 2E-10 -2.61 9E-04  
Dagla -0.64 2E-02 0.36 2E-02 -0.57 7E-03  
Znhit6 -0.64 2E-03 0.40 1E-05 -2.49 3E-07  
Bbs4 -0.64 4E-03 0.12 1E-09 -0.79 1E-02  
Plekhm3 -0.65 2E-04 0.32 6E-08 -1.94 4E-14  
Stam2 -0.65 7E-05 0.08 7E-21 -1.54 3E-13  
Steap2 -0.65 3E-03 0.54 1E-02 -2.49 7E-03  
Prkce -0.66 1E-04 0.19 1E-08 -2.78 7E-13  
Prkci -0.66 1E-03 0.50 3E-07 -1.71 1E-03  
Ptbp2 -0.66 1E-03 0.08 6E-14 -0.87 4E-02  
Masp1 -0.66 1E-04 0.30 3E-06 -4.04 3E-07  
Tdrkh -0.67 3E-02 0.10 3E-25 -6.09 5E-16  
Hes1 -0.67 1E-04 0.57 2E-03 -0.57 2E-02  
Trabd2b -0.67 3E-03 0.20 1E-05 -1.6 8E-09  
Rab11a -0.68 6E-05 0.21 9E-08 -2.81 5E-12  
Antxr2 -0.68 2E-04 0.12 1E-10 -2.19 8E-04  
Bmp2k -0.68 2E-04 0.18 5E-05 -2.96 4E-02  
Lrba -0.69 9E-05 0.27 2E-02 -2.98 3E-04  
Ryk -0.69 6E-05 0.37 5E-03 -0.55 4E-03  
Orc4 -0.69 2E-03 0.04 3E-26 -1.04 3E-02  
Ctif -0.69 1E-03 0.16 1E-08 -1.28 1E-03  
Fam98b -0.69 6E-04 0.26 4E-29 -2.67 7E-13  
Zfx -0.70 3E-03 0.57 7E-09 -0.94 1E-03  
Neo1 -0.70 4E-09 0.41 4E-02 -4.96 6E-06  
Six3 -0.70 2E-02 0.03 5E-35 -3.74 2E-34  
Tmem161b -0.71 2E-03 0.42 4E-36 -0.62 5E-03  
Tmeff2 -0.71 2E-02 0.11 6E-81 -5.16 5E-20  
Uchl5 -0.72 2E-02 0.21 5E-07 -2.97 3E-19  
Usp6nl -0.72 4E-07 0.31 2E-11 -1.81 5E-02  
Nipa2 -0.72 8E-04 0.08 5E-15 -2.59 7E-10  
Ercc6 -0.72 3E-07 0.38 3E-04 -1.16 7E-04  
Tns1 -0.73 4E-03 0.11 2E-12 -4.58 7E-19  
Xpnpep1 -0.73 1E-05 0.29 5E-06 -6.63 7E-20  
Polh -0.73 4E-02 0.34 2E-02 -1.14 2E-03  
Limd2 -0.73 4E-04 0.37 8E-04 -2.28 3E-03  
Atp6v0e -0.74 1E-05 0.45 1E-11 -2.3 2E-02  
Cdk8 -0.74 4E-04 0.26 2E-02 -2.28 4E-07  
Pola1 -0.74 4E-02 0.06 6E-97 -2.98 1E-05  
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Rnf24 -0.75 7E-06 0.18 4E-07 -2.04 7E-07  
Cox7a2 -0.75 2E-03 0.35 3E-03 -0.7 5E-02  
Adpgk -0.75 2E-06 0.12 1E-09 -0.79 1E-02  
Tmem268 -0.75 2E-02 0.03 2E-33 -5.73 1E-12  
Pygb -0.75 2E-03 0.11 2E-12 -2.66 5E-07  
Znfx1 -0.75 1E-04 0.29 8E-07 -4.04 1E-05  
Hccs -0.75 4E-08 0.10 1E-09 -4.08 1E-05  
Efna5 -0.75 3E-04 0.26 1E-04 -1.23 3E-05  
Zbtb21 -0.76 1E-06 0.11 1E-11 -3.59 2E-06  
Col4a1 -0.76 3E-08 0.32 5E-15 -5.7 1E-15  
B3galt1 -0.76 1E-04 0.05 2E-15 -1.36 1E-03  
Il6st -0.76 3E-06 0.16 2E-04 -1.47 3E-02  
Rpp30 -0.76 1E-02 0.16 4E-18 -1.39 8E-05  
Igfbp7 -0.76 8E-03 0.35 6E-07 -3.46 6E-27  
Palld -0.77 1E-03 0.49 2E-04 -2.17 3E-05  
Paqr3 -0.77 1E-03 0.18 5E-05 -2.96 4E-02  
Tspan3 -0.78 1E-09 0.50 5E-03 -0.76 1E-02  
Scarb1 -0.78 4E-05 0.06 4E-14 -1.76 1E-11  
Arfgap1 -0.78 6E-10 0.05 1E-16 -4.63 3E-18  
Smyd4 -0.79 3E-05 0.47 1E-04 -0.53 2E-02  
Plce1 -0.79 3E-03 0.01 1E-34 -5.18 3E-16  
Setmar -0.80 1E-02 0.02 3E-25 -1.56 7E-10  
Ext1 -0.80 6E-09 0.13 8E-08 -1.3 6E-03  
Pdia6 -0.80 8E-04 0.63 1E-04 -1.25 1E-02  
Myef2 -0.80 3E-02 0.24 8E-06 -0.82 3E-04  
Dbr1 -0.80 5E-04 0.14 6E-07 -1.05 3E-03  
Tram2 -0.80 4E-04 0.13 1E-05 -1.42 4E-02  
Mtpn -0.81 4E-08 0.31 3E-03 -2.67 8E-03  
Dph3 -0.82 1E-08 0.51 4E-03 -1.99 1E-05  
Fam171a1 -0.82 2E-06 0.44 2E-08 -1.04 2E-02  
E2f6 -0.82 8E-05 0.57 7E-04 -1.86 5E-04  
Itga8 -0.82 1E-02 0.32 4E-11 -2.68 2E-03  
Dab2 -0.82 8E-06 0.26 1E-04 -4.96 1E-07  
Intu -0.82 1E-04 0.11 2E-12 -2.21 1E-24  
Tenm3 -0.82 4E-04 0.02 9E-20 -5.8 6E-13  
Dkc1 -0.82 2E-02 0.11 2E-12 -4.58 1E-16  
Cxadr -0.83 1E-03 0.28 2E-03 -3.28 2E-06  
Gbf1 -0.83 2E-05 0.22 3E-09 -0.85 2E-05  
Pelo -0.83 4E-05 0.04 9E-74 -1.79 2E-03  
Znrf2 -0.83 2E-10 0.29 9E-04 -1.5 1E-03  
Fgfr1op -0.83 4E-05 0.14 6E-10 -1.25 2E-03  
Fam98a -0.84 5E-04 0.21 5E-72 -1.22 3E-02  
Cxcl12 -0.84 2E-03 0.05 1E-20 -1.41 5E-03  
Hebp2 -0.85 4E-02 0.17 6E-08 -3.12 2E-04  
Mcm4 -0.85 5E-02 0.11 1E-11 -1.36 5E-04  
Slc18a2 -0.86 6E-05 0.65 2E-06 -0.68 1E-03  
Dner -0.86 2E-02 0.13 1E-08 -2.04 2E-16  
Col5a2 -0.86 5E-09 0.51 2E-04 -0.73 3E-02  
Slc39a10 -0.86 9E-06 0.01 1E-52 -3.84 2E-03  
Peak1 -0.86 2E-11 0.63 3E-02 -1.73 1E-03  
Gm11266 -0.87 8E-03 0.29 1E-74 -3.41 1E-08  
Smim13 -0.87 1E-08 0.51 9E-04 -0.9 1E-03  
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Ndc80 -0.87 9E-03 0.07 7E-37 -2.44 2E-09  
Hmmr -0.87 3E-03 0.16 3E-63 -1.75 1E-02  
Fzd8 -0.88 6E-03 0.35 3E-02 -0.84 2E-03  
Traip -0.88 2E-02 0.01 9E-31 -0.57 2E-02  
Uqcc1 -0.88 2E-10 0.26 3E-17 -1.92 8E-11  
Col4a2 -0.89 3E-10 0.32 5E-15 -5.7 1E-15  
Gulp1 -0.89 1E-06 0.25 4E-18 -1.24 3E-03  
Wdr75 -0.90 2E-04 0.43 2E-18 -1.69 3E-04  
Galc -0.90 5E-13 0.39 1E-02 -2.02 6E-03  
Anapc15 -0.90 5E-04 0.40 5E-04 -1.4 1E-05  
Kcnf1 -0.90 6E-03 0.27 1E-04 -1.75 1E-09  
Alcam -0.90 1E-02 0.05 1E-134 -1.39 9E-03  
Rb1cc1 -0.90 2E-06 0.09 1E-148 -2.05 5E-04  
Coro1c -0.91 2E-06 0.26 2E-02 -1.23 2E-02  
Nup205 -0.91 7E-04 0.25 5E-03 -3.92 9E-08  
Mettl15 -0.91 5E-06 0.28 1E-28 -0.87 1E-02  
Tpbg -0.92 1E-12 0.46 5E-06 -2.04 3E-03  
Add3 -0.94 1E-06 0.12 3E-22 -2.38 2E-09  
Shcbp1 -0.95 1E-02 0.07 2E-25 -1.38 1E-02  
Cacna1c -0.95 4E-07 0.24 7E-03 -3.04 4E-14  
Topors -0.95 7E-10 0.40 3E-02 -3.21 6E-04  
Pdlim1 -0.96 8E-04 0.23 4E-02 -2.27 2E-04  
Wdr1 -0.96 2E-13 0.17 1E-06 -2.22 1E-03  
Pdlim5 -0.96 8E-09 0.12 3E-141 -3.02 6E-04  
Tmem47 -0.96 5E-07 0.02 3E-25 -3.02 6E-13  
Glis3 -0.97 3E-05 0.28 2E-03 -0.86 7E-04  
Macf1 -0.97 3E-05 0.11 2E-12 -1.69 5E-05  
Six2 -0.97 7E-05 0.03 5E-35 -3.74 2E-34  
Kif11 -0.98 6E-03 0.23 4E-02 -1.75 5E-02  
Snx24 -0.99 1E-06 0.40 7E-04 -0.92 4E-02  
Tipin -0.99 4E-03 0.14 7E-16 -5.29 2E-25  
Tnnt2 -0.99 1E-03 0.41 6E-03 -0.96 9E-05  
Dmd -1.00 8E-11 0.09 8E-13 -3.02 6E-13  
Arhgap26 -1.00 3E-05 0.06 8E-13 -1.45 3E-02  
Prim2 -1.01 2E-03 0.29 5E-02 -2.22 1E-03  
Cnn3 -1.01 2E-07 0.60 2E-02 -0.7 2E-02  
Tanc2 -1.02 8E-05 0.09 1E-10 -3.92 3E-08  
Kif18a -1.02 2E-03 0.28 1E-28 -0.87 1E-02  
Bbs5 -1.03 2E-06 0.13 2E-18 -2.53 1E-04  
Phldb2 -1.03 1E-12 0.02 1E-102 -2.72 4E-04  
Pkia -1.04 8E-13 0.13 1E-08 -5.68 8E-15  
Swap70 -1.04 1E-12 0.19 1E-10 -0.99 4E-02  
Ctnnd1 -1.04 9E-07 0.38 1E-38 -0.89 3E-02  
Lrr1 -1.06 2E-02 0.05 1E-16 -2.79 4E-04  
Zfp229 -1.06 3E-08 0.12 1E-69 -0.59 7E-03  
Snx7 -1.06 5E-09 0.17 9E-06 -5.4 1E-15  
Atp11a -1.06 6E-17 0.08 8E-28 -2.98 8E-15  
Zfp697 -1.07 9E-07 0.37 2E-04 -1.06 2E-03  
Nmnat1 -1.07 5E-10 0.23 1E-08 -1.23 5E-03  
Mcm10 -1.07 1E-02 0.31 1E-06 -0.86 5E-02  
Adamts5 -1.08 3E-06 0.08 6E-14 -3.41 1E-05  
Crim1 -1.08 4E-07 0.43 5E-05 -2.69 2E-11  
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Mrc2 -1.08 6E-09 0.03 7E-85 -0.54 2E-02  
Cenpk -1.08 5E-04 0.24 2E-38 -1.16 2E-02  
Atxn1 -1.09 7E-10 0.18 1E-08 -1.55 3E-03  
Msx1 -1.09 1E-05 0.06 1E-33 -7.36 9E-27  
Slc7a1 -1.10 1E-03 0.19 1E-05 -2.87 4E-05  
Cyb561 -1.10 8E-05 0.19 1E-08 -3.92 3E-08  
Mcts2 -1.10 3E-09 0.47 4E-05 -1.23 5E-06  
Gins1 -1.12 7E-03 0.32 2E-05 -3.21 3E-02  
Tsc22d2 -1.12 4E-13 0.44 2E-23 -2.55 4E-04  
Mturn -1.13 1E-03 0.29 9E-04 -1.5 1E-03  
Phgdh -1.13 1E-02 0.36 2E-14 -0.76 2E-02  
Pcdh18 -1.14 8E-13 0.01 1E-36 -4.72 3E-05  
Rif1 -1.14 4E-07 0.30 3E-02 -1.2 3E-04  
Ptprd -1.15 5E-03 0.26 9E-04 -1.89 3E-03  
Taf4b -1.15 2E-04 0.46 1E-02 -0.93 3E-02  
Trmt61a -1.16 1E-05 0.34 2E-09 -2.01 9E-03  
Tnfaip3 -1.16 8E-06 0.47 4E-11 -0.92 1E-03  
Hs6st1 -1.16 2E-06 0.06 1E-11 -1.92 2E-02  
Nup160 -1.17 7E-06 0.16 3E-05 -3.12 4E-05  
Snai2 -1.17 8E-05 0.30 5E-08 -0.78 1E-03  
Arhgap29 -1.18 2E-10 0.32 1E-02 -1.32 3E-04  
Atp1a1 -1.18 8E-12 0.36 2E-02 -0.76 6E-04  
Gca -1.18 3E-03 0.14 7E-19 -1.14 6E-03  
Dut -1.18 2E-03 0.48 2E-04 -4.3 2E-04  
Rbms1 -1.18 1E-20 0.18 1E-08 -1.7 5E-05  
Fendrr -1.18 8E-03 0.08 7E-21 -2.71 2E-11  
Clmp -1.18 1E-05 0.37 5E-29 -1.37 2E-06  
Srd5a1 -1.19 4E-05 0.29 5E-02 -2.51 1E-04  
Il7 -1.20 3E-04 0.30 5E-03 -1.93 2E-06  
Col4a6 -1.20 4E-09 0.40 6E-17 -0.88 1E-02  
Zdhhc13 -1.21 4E-09 0.07 3E-09 -1.22 8E-06  
Col3a1 -1.21 2E-09 0.51 2E-04 -0.73 3E-02  
Adam9 -1.23 9E-13 0.51 3E-18 -1.35 7E-05  
Nmt2 -1.23 8E-15 0.40 3E-02 -1.04 2E-02  
Hells -1.23 2E-03 0.23 3E-04 -2.94 4E-07  
Pde4b -1.24 7E-16 0.17 9E-06 -1.37 6E-03  
Enpp1 -1.24 7E-04 0.43 1E-19 -1.48 2E-03  
Cst3 -1.24 3E-05 0.09 2E-37 -1.79 1E-04  
Cers6 -1.25 2E-11 0.04 8E-25 -4.84 2E-09  
Gnao1 -1.25 8E-05 0.12 2E-14 -1.24 5E-03  
Otx1 -1.26 9E-09 0.08 2E-56 -2.42 1E-08  
Serp1 -1.26 7E-19 0.44 2E-23 -2.55 4E-04  
Depdc1a -1.26 8E-03 0.60 3E-02 -4.11 3E-03  
Ergic1 -1.27 3E-08 0.45 1E-11 -2.3 2E-02  
Fat1 -1.27 2E-09 0.11 1E-63 -2.03 2E-06  
Agap1 -1.28 2E-15 0.32 6E-03 -1.45 2E-09  
Glce -1.28 1E-18 0.20 7E-46 -2.95 4E-05  
Snx30 -1.28 7E-10 0.17 2E-14 -2.27 5E-05  
Tpd52 -1.29 2E-03 0.26 3E-19 -2.66 1E-08  
Hs6st2 -1.29 1E-08 0.02 3E-25 -5.13 2E-11  
Bcl6 -1.30 2E-15 0.38 3E-02 -1.32 3E-03  
Arap2 -1.31 1E-10 0.07 3E-09 -1.75 6E-03  
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Bmpr1b -1.32 3E-03 0.07 2E-25 -5.86 2E-13  
Mid1 -1.32 2E-18 0.02 6E-269 -4.73 3E-19  
S1pr1 -1.32 3E-05 0.49 8E-08 -4.35 3E-06  
C030034I22Rik -1.33 1E-02 0.49 1E-03 -1.1 3E-02  
Cask -1.33 7E-28 0.35 3E-05 -2.58 4E-04  
Tnfaip6 -1.33 5E-09 0.30 3E-02 -1.2 3E-04  
Loxl1 -1.34 4E-10 0.19 8E-08 -0.83 8E-03  
Dhfr -1.34 5E-04 0.21 5E-07 -0.74 4E-02  
Map4k3 -1.34 6E-23 0.64 5E-06 -1.39 4E-05  
Ifitm3 -1.35 2E-09 0.49 1E-03 -1.86 2E-02  
Plcb4 -1.35 2E-18 0.06 4E-14 -1.96 5E-05  
Plcxd2 -1.37 1E-07 0.18 1E-22 -5.43 1E-10  
Col4a5 -1.37 8E-12 0.20 3E-27 -1.72 4E-04  
Entpd6 -1.38 1E-12 0.11 2E-12 -2.66 5E-07  
Lhfp -1.39 3E-23 0.20 3E-36 -2.18 4E-03  
Plekha1 -1.40 2E-12 0.11 1E-06 -3.99 3E-04  
Ptgs2os -1.40 1E-03 0.29 3E-20 -2.98 1E-09  
Fam72a -1.41 7E-06 0.03 3E-57 -4.39 4E-07  
Slit2 -1.41 4E-13 0.15 4E-06 -3.1 2E-04  
Hspa5 -1.41 6E-16 0.47 3E-04 -2.88 4E-12  
Pfkp -1.41 1E-28 0.14 5E-23 -1.96 8E-03  
Epha4 -1.42 3E-10 0.10 3E-85 -4.01 2E-05  
Nhsl2 -1.43 1E-11 0.11 1E-06 -2.65 3E-21  
Gm13889 -1.43 1E-03 0.19 5E-05 -1.74 1E-13  
Slc7a5 -1.43 2E-05 0.29 2E-22 -0.74 2E-02  
Tbx18 -1.45 2E-18 0.04 2E-179 -6.72 8E-21  
Cenpi -1.45 1E-05 0.40 8E-13 -4.52 1E-10  
Myrf -1.45 3E-04 0.36 2E-02 -0.57 7E-03  
Six1 -1.46 5E-14 0.05 1E-182 -7.03 1E-50  
B4galt4 -1.46 5E-20 0.11 3E-22 -2.52 2E-03  
Pla2g4c -1.47 3E-02 0.04 2E-23 -2.55 1E-05  
Podxl -1.48 2E-07 0.15 2E-23 -1.8 2E-08  
Thsd7a -1.49 2E-03 0.09 9E-12 -0.9 2E-02  
Ptprg -1.49 1E-29 0.31 6E-06 -3.85 2E-09  
Chrm3 -1.50 2E-03 0.07 3E-09 -3.22 5E-03  
Eif2ak4 -1.50 1E-22 0.63 2E-03 -1.82 4E-02  
Prkaa2 -1.52 3E-07 0.34 1E-03 -1.63 7E-04  
Fam83c -1.54 3E-02 0.31 4E-11 -0.51 1E-02  
Robo1 -1.54 1E-02 0.04 5E-22 -2.96 8E-07  
Tln2 -1.54 1E-16 0.56 4E-03 -1.75 5E-05  
Amot -1.54 1E-38 0.19 3E-09 -5.06 4E-12  
Rspo2 -1.55 1E-06 0.42 2E-05 -2.16 3E-08  
Slco3a1 -1.55 4E-18 0.35 3E-05 -0.81 1E-02  
Rhoj -1.57 2E-22 0.47 1E-02 -4.06 1E-06  
Sp8 -1.57 4E-11 0.18 4E-17 -1.22 4E-02  
Sytl2 -1.58 3E-17 0.22 3E-25 -2.32 3E-02  
Ifih1 -1.58 1E-05 0.14 7E-19 -1.14 6E-03  
Cass4 -1.59 4E-02 0.22 6E-12 -1.21 3E-02  
Jph2 -1.61 3E-03 0.06 3E-23 -1.5 1E-12  
Slc24a3 -1.61 3E-15 0.12 2E-16 -1.45 3E-05  
Rnd3 -1.63 5E-31 0.34 2E-02 -3.37 3E-05  
Nedd9 -1.64 7E-27 0.04 5E-22 -2.06 2E-03  
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Cpd -1.64 7E-31 0.08 4E-39 -1.19 9E-03  
Manf -1.64 8E-19 0.32 4E-07 -0.71 4E-03  
Cald1 -1.64 2E-52 0.55 2E-03 -3.9 8E-10  
Foxd2os -1.65 2E-09 0.04 4E-29 -6.75 8E-21  
Fabp5 -1.65 3E-04 0.15 4E-06 -4.58 4E-06  
Zfp760 -1.65 7E-19 0.12 1E-69 -0.59 7E-03  
Slc25a25 -1.65 9E-22 0.32 1E-05 -2.85 8E-05  
Hunk -1.65 4E-15 0.35 7E-10 -1.52 2E-07  
Itgb1 -1.66 3E-39 0.20 4E-25 -2.25 2E-03  
Tpm1 -1.66 1E-26 0.29 3E-18 -1.12 1E-03  
Csrnp1 -1.66 6E-16 0.27 1E-13 -1.7 9E-03  
Optc -1.66 3E-04 0.30 3E-07 -0.97 2E-02  
Gm12603 -1.67 1E-04 0.60 4E-11 -2.04 1E-03  
Proser2 -1.68 8E-06 0.24 2E-06 -2.09 1E-02  
Nod1 -1.69 4E-09 0.01 2E-40 -7.26 2E-25  
Runx1 -1.69 3E-20 0.17 1E-06 -1.45 5E-03  
Rora -1.69 1E-03 0.01 2E-40 -2.04 1E-05  
Col18a1 -1.69 2E-27 0.26 2E-02 -1.65 1E-05  
Akap12 -1.72 2E-38 0.58 7E-03 -2.41 2E-06  
Akip1 -1.73 8E-28 0.40 5E-04 -2.97 9E-03  
Heg1 -1.73 3E-13 0.24 3E-04 -1.81 3E-02  
Nectin1 -1.73 2E-15 0.24 1E-03 -1.29 2E-07  
Ptprj -1.73 3E-38 0.16 2E-04 -3.12 4E-05  
Shroom3 -1.73 1E-12 0.25 3E-22 -2.78 3E-15  
Pde1a -1.74 6E-11 0.06 5E-27 -3.11 3E-07  
Il1rapl1 -1.74 2E-02 0.13 1E-08 -1.7 3E-03  
Apol9a -1.74 1E-02 0.09 1E-18 -3.42 1E-10  
Bnc2 -1.75 5E-16 0.13 1E-19 -5.14 1E-15  
Plpp3 -1.76 2E-13 0.34 1E-03 -1.63 7E-04  
Sulf1 -1.77 4E-11 0.21 2E-08 -2.26 4E-03  
Dlx2 -1.78 2E-11 0.04 0E+00 -4.87 2E-09  
Tox -1.80 4E-04 0.01 9E-57 -5.44 5E-09  
Gpsm1 -1.80 2E-34 0.24 7E-28 -1.32 3E-04  
Hpse -1.81 5E-02 0.01 8E-59 -1.31 3E-06  
Fzd5 -1.81 8E-34 0.51 3E-07 -1.28 5E-02  
Dhrs3 -1.82 4E-09 0.29 8E-03 -0.72 6E-03  
Ezr -1.82 5E-35 0.12 4E-28 -1.6 1E-14  
Ccna1 -1.84 9E-04 0.08 6E-22 -2.79 8E-07  
Sema3c -1.84 3E-14 0.03 3E-57 -4.36 3E-05  
Dusp19 -1.84 4E-19 0.37 5E-03 -0.77 8E-04  
Lrch2 -1.88 2E-26 0.26 7E-10 -2.4 3E-05  
Sh3gl3 -1.92 1E-08 0.73 9E-07 -1.09 5E-02  
Adam12 -1.92 4E-20 0.10 2E-20 -2.85 4E-16  
Dnah6 -1.94 5E-02 0.25 5E-08 -1.39 5E-04  
Tpd52l1 -1.97 7E-04 0.19 1E-05 -3.85 7E-08  
Tmem30b -1.97 5E-02 0.20 2E-15 -3.96 5E-10  
Hipk2 -1.98 1E-17 0.09 1E-18 -0.61 5E-02  
Grk5 -1.99 2E-22 0.14 6E-07 -5.32 2E-07  
Dusp4 -2.00 2E-22 0.55 9E-05 -0.81 8E-05  
Adra1d -2.01 4E-12 0.07 3E-32 -2.12 9E-05  
Abi3bp -2.01 2E-03 0.18 1E-03 -3.51 8E-06  
Pmaip1 -2.03 1E-04 0.15 4E-06 -1.39 3E-02  
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Ccdc187 -2.03 1E-04 0.16 2E-10 -1.26 8E-05  
Oasl2 -2.05 2E-03 0.01 3E-98 -0.67 5E-03  
Gdf6 -2.06 2E-29 0.38 2E-04 -1.01 3E-02  
Gm9767 -2.07 4E-02 0.15 4E-06 -5.65 2E-12  
Ugcg -2.07 3E-42 0.25 5E-26 -0.87 1E-03  
Tmem200a -2.08 5E-17 0.15 4E-06 -5.65 2E-12  
Boc -2.09 6E-33 0.20 1E-05 -1.9 3E-06  
Acta2 -2.09 4E-33 0.68 6E-03 -0.8 8E-03  
Clcn5 -2.11 3E-30 0.33 5E-23 -1.06 3E-02  
Snai3 -2.12 9E-03 0.25 3E-02 -0.42 5E-02  
Inhba -2.16 4E-23 0.01 2E-42 -1.76 1E-03  
Gm17750 -2.17 2E-04 0.20 6E-174 -1.19 2E-02  
Serpine2 -2.17 6E-05 0.05 4E-41 -5.44 2E-10  
Myzap -2.18 8E-04 0.31 6E-06 -1.92 2E-04  
Tll1 -2.19 4E-08 0.04 5E-22 -0.96 4E-03  
Fam198a -2.19 3E-04 0.25 3E-02 -1.27 1E-02  
Sgcd -2.21 2E-17 0.18 2E-11 -3.84 3E-06  
Ngf -2.22 1E-21 0.45 6E-03 -0.53 4E-03  
Arl5a -2.22 1E-39 0.09 3E-171 -5.92 8E-12  
Igll1 -2.27 2E-02 0.35 6E-03 -2.36 3E-04  
Pex5l -2.29 2E-02 0.01 1E-50 -3.51 2E-15  
Serpinf1 -2.31 6E-32 0.25 4E-05 -0.53 2E-02  
Arhgef5 -2.31 5E-07 0.11 1E-11 -0.92 6E-03  
Fibin -2.32 3E-09 0.02 5E-18 -0.9 2E-04  
Itih2 -2.33 7E-05 0.07 3E-09 -5.23 1E-09  
Trpm3 -2.34 1E-11 0.10 3E-27 -6.06 7E-14  
Tmem71 -2.36 2E-02 0.17 6E-08 -0.74 4E-02  
Lin7a -2.37 2E-02 0.02 9E-20 -5.08 1E-08  
Prl2c3 -2.37 2E-02 0.60 2E-04 -1.25 2E-02  
Dpyd -2.37 6E-03 0.15 1E-38 -2.51 1E-02  
Slc8a1 -2.38 1E-20 0.08 4E-23 -1.32 1E-02  
Pag1 -2.40 3E-39 0.15 4E-06 -4.58 4E-06  
Eya2 -2.40 2E-04 0.01 1E-54 -5.83 1E-13  
Gpr1 -2.40 1E-02 0.05 7E-49 -0.78 3E-02  
Camk4 -2.41 1E-10 0.24 2E-26 -2.07 2E-03  
Pip4k2a -2.42 2E-63 0.11 2E-43 -1.5 8E-05  
Flrt2 -2.46 6E-41 0.07 7E-45 -5.97 2E-13  
Lox -2.49 2E-55 0.52 4E-05 -2.05 2E-08  
Gnai1 -2.49 5E-11 0.02 5E-18 -2.52 1E-02  
Dusp1 -2.50 1E-26 0.62 4E-02 -0.58 5E-02  
Lyn -2.51 7E-47 0.07 1E-35 -1.05 9E-03  
Cttnbp2 -2.52 1E-08 0.22 1E-30 -1.17 3E-03  
Ripk2 -2.53 1E-45 0.31 3E-03 -3.5 2E-05  
Pappa -2.53 5E-25 0.14 1E-25 -1.11 2E-04  
Lgsn -2.54 1E-02 0.23 4E-02 -2.93 4E-08  
Il1rap -2.55 3E-44 0.29 8E-07 -3.39 8E-06  
Pitx3 -2.57 1E-02 0.22 3E-09 -0.85 2E-05  
Pawr -2.58 9E-29 0.13 4E-50 -1.62 9E-04  
Ptprq -2.58 1E-02 0.11 5E-28 -2.04 3E-02  
Epha7 -2.60 8E-05 0.11 1E-07 -1.41 2E-04  
Dock3 -2.62 1E-36 0.32 4E-07 -0.71 4E-03  
Vgll3 -2.64 4E-29 0.24 5E-49 -4.61 1E-06  
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Palm2 -2.64 8E-11 0.10 2E-14 -1.28 1E-04  
Irs1 -2.65 1E-49 0.24 6E-08 -1.32 3E-04  
Cntnap2 -2.66 3E-04 0.01 2E-40 -3.34 4E-06  
Ptgs2 -2.66 9E-15 0.29 3E-20 -2.98 1E-09  
Lama2 -2.66 6E-28 0.22 4E-16 -2.3 1E-23  
Apob -2.69 7E-03 0.28 7E-05 -1.17 1E-03  
Emx2 -2.72 1E-52 0.27 2E-63 -1.21 5E-07  
Rsad2 -2.73 3E-03 0.01 9E-57 -0.89 3E-02  
Lmcd1 -2.73 1E-47 0.18 2E-11 -0.97 2E-04  
Lhx2 -2.74 4E-37 0.17 3E-29 -1.67 5E-05  
Moxd1 -2.75 6E-03 0.37 1E-06 -1.93 2E-02  
Efnb2 -2.77 8E-69 0.51 6E-07 -1.21 2E-04  
Arhgap31 -2.78 9E-56 0.14 5E-23 -3.38 3E-06  
Foxd2 -2.85 5E-15 0.04 4E-29 -6.75 8E-21  
Ntf3 -2.85 7E-04 0.11 2E-16 -5.24 2E-11  
Spats2l -2.86 6E-11 0.06 1E-52 -3.59 2E-03  
Tnc -2.87 2E-64 0.19 4E-41 -2.32 5E-07  
Carmn -2.88 1E-09 0.25 6E-06 -1.27 4E-12  
Rbfox1 -2.91 2E-03 0.16 1E-08 -2.89 2E-07  
Aldh1a1 -2.94 4E-04 0.38 1E-02 -1.93 6E-03  
Pax6 -2.95 5E-109 0.14 2E-40 -4.69 1E-10  
Kcnq5 -2.98 7E-52 0.11 1E-08 -4.89 2E-07  
Wbscr17 -2.98 8E-60 0.14 1E-36 -3.84 3E-07  
Klf2 -2.98 2E-44 0.11 1E-06 -1.38 9E-05  
Cxcl1 -2.98 3E-13 0.53 1E-04 -1.58 1E-02  
Fbxl7 -2.99 1E-25 0.08 7E-21 -4.59 9E-10  
Abcc12 -2.99 1E-35 0.26 1E-04 -1.54 2E-04  
Spry1 -3.00 3E-40 0.17 1E-18 -0.89 3E-02  
Chsy3 -3.01 2E-11 0.11 1E-08 -2.2 1E-04  
Slco1a5 -3.02 2E-26 0.47 1E-24 -1.44 1E-02  
Trank1 -3.03 3E-07 0.02 9E-20 -4 2E-12  
Gabrg3 -3.03 2E-03 0.02 9E-20 -5.49 3E-18  
Cdh11 -3.03 4E-116 0.00 1E-123 -4.91 7E-13  
Grb10 -3.05 3E-21 0.30 5E-08 -5.59 9E-12  
Dcn -3.07 9E-07 0.02 9E-20 -4.65 1E-06  
Vit -3.09 9E-38 0.23 1E-24 -4.4 3E-13  
Itga4 -3.12 1E-24 0.34 6E-16 -2.02 6E-03  
Tspan12 -3.14 1E-25 0.18 1E-03 -2.73 7E-06  
Gpr176 -3.16 6E-12 0.30 2E-14 -1.82 4E-02  
Neb -3.17 5E-13 0.01 6E-87 -5.95 4E-52  
Steap1 -3.19 1E-37 0.23 4E-02 -2.49 7E-03  
Opn5 -3.20 8E-04 0.15 2E-43 -1.95 2E-04  
F3 -3.23 2E-127 0.69 2E-02 -1.27 1E-03  
Cftr -3.23 2E-26 0.22 1E-30 -1.17 3E-03  
Hoxb9 -3.28 8E-05 0.06 1E-11 -6.72 2E-19  
Nlgn1 -3.28 1E-04 0.13 1E-08 -3.43 1E-04  
Tceal7 -3.32 2E-04 0.02 3E-86 -2.55 1E-05  
Samd12 -3.37 1E-04 0.20 2E-03 -2.93 2E-03  
Ascl2 -3.37 4E-04 0.06 1E-11 -3.07 8E-06  
Ptgs2os2 -3.37 3E-04 0.20 2E-13 -4.06 4E-03  
Nkain2 -3.39 7E-12 0.23 3E-41 -5.06 9E-09  
Nova1 -3.39 2E-15 0.16 1E-19 -4.44 7E-22  
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Tslp -3.39 5E-05 0.32 6E-19 -2.82 8E-16  
Tnfsf18 -3.41 4E-10 0.28 1E-02 -4.89 6E-08  
Nsg1 -3.42 1E-33 0.09 2E-39 -4.1 1E-08  
Aass -3.43 3E-04 0.01 1E-36 -6.61 9E-20  
Luzp2 -3.46 2E-04 0.01 2E-48 -2.15 4E-20  
Dkk2 -3.47 2E-10 0.01 0E+00 -5.73 9E-12  
Akain1 -3.47 2E-04 0.11 2E-44 -1.1 3E-02  
Samd5 -3.49 1E-08 0.02 9E-20 -2.97 4E-13  
Mdga2 -3.52 2E-05 0.05 6E-18 -1.05 4E-02  
Slc14a1 -3.54 2E-04 0.24 5E-10 -0.99 3E-02  
Foxf1 -3.54 6E-40 0.08 7E-21 -2.71 2E-11  
Ptprb -3.55 2E-09 0.25 2E-27 -3.67 3E-08  
Ptchd4 -3.55 3E-27 0.05 2E-114 -1.44 4E-03  
Bmp6 -3.56 2E-22 0.30 5E-03 -1.36 4E-05  
Cep126 -3.61 4E-28 0.26 6E-09 -2.89 2E-03  
Hhip -3.63 1E-15 0.23 1E-03 -1.74 8E-03  
Itga1 -3.64 1E-90 0.03 9E-46 -3.66 3E-07  
Dmrta2 -3.70 5E-66 0.04 4E-29 -1.86 5E-06  
E330013P04Rik -3.71 7E-09 0.35 1E-05 -2.39 4E-04  
Has2 -3.74 8E-34 0.29 2E-11 -6.31 2E-15  
Tusc1 -3.75 9E-19 0.04 5E-22 -7.06 9E-21  
Fgf5 -3.78 2E-21 0.06 8E-13 -1.63 8E-07  
Sema3a -3.80 4E-52 0.09 1E-270 -5.77 8E-12  
Adam19 -3.80 8E-52 0.01 2E-42 -3.4 1E-18  
Mme -3.88 8E-19 0.09 9E-12 -2.92 3E-03  
Nkain4 -3.91 1E-07 0.05 1E-16 -4.63 3E-18  
Gm16897 -3.91 1E-16 0.25 4E-47 -2.91 1E-02  
Baiap2l1 -3.93 6E-40 0.01 3E-67 -5.59 6E-11  
Syt1 -3.95 2E-21 0.06 8E-13 -2.56 3E-11  
Zfhx4 -3.95 3E-96 0.08 3E-32 -5.07 2E-07  
Brinp1 -3.96 9E-06 0.00 2E-255 -6.48 9E-19  
Casp14 -4.03 6E-06 0.03 5E-35 -7.79 6E-31  
Pax6os1 -4.07 4E-06 0.01 9E-31 -4.96 3E-08  
Adcy1 -4.08 2E-36 0.28 2E-03 -1.68 4E-03  
Gja5 -4.10 4E-08 0.29 8E-03 -1.83 7E-05  
Ptprt -4.14 9E-15 0.01 1E-36 -2.89 4E-05  
Serpine1 -4.15 2E-53 0.41 7E-09 -1.34 3E-04  
Igf1 -4.17 8E-59 0.16 2E-07 -1.5 2E-04  
Zic5 -4.21 2E-55 0.12 3E-122 -0.57 5E-02  
Mb21d1 -4.27 2E-24 0.25 2E-04 -1.78 7E-12  
Lor -4.27 8E-07 0.07 2E-10 -3.27 8E-04  
Kcnh5 -4.32 1E-20 0.07 1E-19 -4.06 1E-06  
Zic2 -4.34 2E-81 0.12 3E-122 -0.57 5E-02  
Cyfip2 -4.39 5E-97 0.09 1E-10 -6.03 6E-15  
Tacr1 -4.40 1E-13 0.29 3E-36 -1.38 2E-05  
Ism1 -4.40 1E-26 0.14 6E-10 -3.95 3E-04  
Wnt2 -4.49 9E-09 0.17 1E-30 -3.48 3E-13  
Eva1a -4.59 3E-35 0.02 9E-20 -1.79 2E-12  
Itgb6 -4.65 8E-13 0.26 6E-09 -2.12 4E-03  
Epas1 -4.66 2E-45 0.28 6E-08 -2.78 7E-13  
Galnt18 -4.69 6E-77 0.06 1E-55 -4 3E-06  
Jazf1 -4.77 1E-53 0.20 1E-05 -3.88 3E-07  
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Acss1 -4.84 1E-26 0.13 8E-08 -5.38 7E-10  
Tmem56 -4.87 8E-50 0.15 1E-44 -3.92 1E-08  
Zfp423 -4.94 2E-74 0.07 1E-27 -2.71 3E-02  
Gm5089 -4.96 1E-21 0.23 2E-59 -0.86 3E-02  
Stox2 -4.99 8E-58 0.07 3E-09 -1.07 3E-02  
Pax2 -5.01 4E-66 0.07 2E-10 -6.16 2E-14  
Cdh6 -5.06 4E-15 0.01 9E-31 -2.84 4E-04  
Cd34 -5.19 2E-114 0.25 4E-47 -2.91 1E-02  
Hgf -5.24 5E-11 0.13 8E-08 -2.23 4E-02  
Lrrc4c -5.32 3E-23 0.07 2E-10 -0.9 2E-03  
Mbnl3 -5.37 9E-14 0.07 2E-10 -5.16 5E-09  
Rassf6 -5.39 2E-36 0.54 1E-06 -1.83 6E-15  
Chrdl1 -5.46 3E-131 0.48 4E-07 -2.47 7E-03  
A730020M07Rik -5.46 7E-16 0.26 4E-22 -1.45 6E-04  
Prdm8 -5.54 3E-30 0.06 8E-13 -1.63 8E-07  
Wnk2 -5.60 4E-48 0.24 5E-05 -1.38 3E-02  
Alx1 -5.62 3E-13 0.01 1E-54 -7.34 2E-36  
Plxdc2 -5.73 4E-20 0.02 9E-20 -6.5 1E-17  
Rasgrp3 -5.93 3E-107 0.04 8E-39 -1.55 1E-03  
Chodl -5.93 3E-21 0.12 1E-09 -1.53 2E-03  
Dach1 -5.94 3E-15 0.02 8E-69 -1.18 2E-02  
Prdm6 -5.97 2E-15 0.03 1E-39 -7.12 1E-24  
Aff3 -5.98 6E-64 0.07 2E-10 -5.45 8E-11  
Arx -5.99 7E-71 0.08 2E-127 -5.33 2E-12  
Cacnb4 -6.01 1E-116 0.03 3E-66 -2.52 1E-02  
Oasl1 -6.05 1E-23 0.01 6E-259 -0.67 5E-03  
Speer3 -6.15 3E-34 0.07 3E-09 -5.06 2E-10  
Alx4 -6.21 2E-31 0.01 1E-54 -7.01 2E-23  
Igsf11 -6.26 3E-32 0.02 9E-20 -3.9 7E-05  
Grem2 -6.30 3E-24 0.01 1E-109 -6.57 7E-19  
Rtn1 -6.34 2E-120 0.11 3E-23 -0.75 2E-03  
Zic3 -6.39 3E-286 0.13 6E-95 -2.52 3E-04  
Tmem45a -6.46 7E-124 0.04 7E-53 -1.73 2E-04  
Ptgis -6.52 1E-39 0.01 1E-52 -1.68 9E-18  
Igfbp2 -6.53 2E-176 0.05 3E-28 -1.88 9E-17  
Rims1 -6.55 1E-19 0.11 1E-07 -4.89 2E-07  
Svep1 -6.65 8E-75 0.02 3E-25 -5.02 6E-14  
Adm -6.66 2E-224 0.45 2E-08 -0.86 4E-02  
Sema3e -6.69 1E-85 0.02 2E-84 -1.35 3E-07  
Eya1 -6.87 1E-159 0.04 1E-199 -1.46 2E-05  
Plekhg1 -6.88 9E-36 0.71 3E-02 -0.76 1E-05  
Cthrc1 -6.92 5E-38 0.26 1E-07 -1.23 3E-04  
Crct1 -6.96 5E-84 0.45 3E-03 -5.36 2E-10  
Pax3 -7.00 1E-31 0.62 4E-02 -2.68 1E-04  
Lrp2 -7.03 9E-257 0.33 6E-06 -2.47 3E-18  
Tmem163 -7.29 1E-87 0.10 2E-18 -1 1E-03  
Slc35f1 -7.35 4E-196 0.02 3E-25 -6.48 3E-17  
Ptprz1 -7.74 2E-34 0.01 2E-38 -6.17 2E-14  
Slco4a1 -7.83 4E-44 0.10 1E-38 -2.08 2E-02  
Zic4 -8.13 2E-177 0.11 6E-81 -2.22 2E-10  
Zic1 -8.22 0E+00 0.08 2E-190 -2.21 3E-15  



























Tmem35a -8.70 4E-98 0.40 8E-13 -4.52 1E-10  
Npr3 -8.85 1E-181 0.01 1E-36 -5.38 1E-38  
Neto1 -8.94 4E-76 0.02 1E-168 -1.79 2E-03  
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SI Appendix Table S3. Genes with concordant gene expression in human GSCs and mouse GBM cells 
Genes Human GSCs                   Linear Fold Change (M/F) 
Human GSCs 
Adjusted p-value 
Mouse GBM Cells        
Linear Fold Change (M/F) 
Mouse GBM Cells 
Adjusted p-value 
DDX3Y 1527.91 3.99E-271 6.37 6.92E-03 
APBB1IP 59.00 4.01E-02 6.77 3.37E-20 
NSG2 22.47 1.40E-04 19.41 7.01E-14 
SYT13 18.46 6.74E-04 3.58 2.37E-04 
CRABP1 18.01 3.86E-04 11.18 8.59E-05 
GLT1D1 13.71 2.01E-03 13.94 1.11E-13 
GPR37L1 10.02 6.59E-03 5.50 1.54E-02 
RET 9.98 3.28E-04 7.16 9.57E-05 
NRXN1 9.51 3.54E-02 4.70 9.20E-09 
DOC2B 9.50 4.06E-03 5.42 4.08E-04 
CAMK1G 7.97 4.31E-02 6.64 4.83E-03 
ALDH1L1 7.01 5.14E-03 14.61 2.63E-05 
GFRA1 6.97 2.40E-02 2.94 2.96E-06 
TEK 6.68 4.10E-02 13.64 6.98E-09 
FUT9 6.52 3.28E-02 13.66 6.15E-10 
SCG3 6.00 2.34E-02 9.00 1.03E-04 
GPD1 5.83 4.57E-03 5.21 8.43E-17 
STXBP2 5.28 1.50E-02 3.82 4.74E-05 
NOTUM 5.21 2.34E-02 5.37 1.33E-08 
TMEM151B 4.66 1.50E-02 2.98 6.61E-03 
KCNAB1 4.58 3.09E-03 5.94 5.19E-20 
PHYHD1 4.51 4.10E-02 6.36 3.88E-05 
ATP8A1 4.09 6.83E-03 6.09 1.15E-30 
MYO7A 4.09 9.18E-03 12.17 9.78E-20 
WNT10A 4.03 2.05E-02 9.58 5.30E-05 
AOC3 3.33 1.70E-02 6.13 9.24E-10 
HID1 3.26 2.28E-02 8.08 4.06E-38 
PCDHB15 2.88 5.39E-03 3.69 4.72E-02 
ADHFE1 2.86 2.09E-02 10.56 1.01E-17 
RAPGEF5 2.85 4.76E-02 2.85 1.09E-05 
ITGA10 0.27 4.66E-02 0.25 1.86E-08 
CARMN 0.20 3.19E-02 0.14 1.35E-09 
SERPINF1 0.10 1.70E-03 0.20 6.38E-32 
XIST 0.0018 8.81E-112 0.0088 4.13E-49 
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SI Appendix Table S5. Real-time quantitative PCR primers and lentivirus shRNA target sequences 
Target Forward qPCR primer Reverse qPCR primer Mouse shRNA target sequence 
Mouse Brd2 TGCTGCAAAACGTGACTC GTAAAGCTGGTACAGAAGCC CAGCCCAAGAAATCTAAGAAA 
Mouse Brd3 GAAAAAGGCTCCCACCAAG GCTAAGTTGTCGCTTTTCATC CCTCTCCCTTAGTAACTTGAA 
Mouse Brd4 GGAACTTCCTCCCAAAAAGAC TGCCGCTTCTCCTCATAAG GCCATCTACACTACGAGAGTT 
